Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
SLC6A13	GAT2	ENSG00000010379	Solute carrier family 6 member 13	Q9NSD5	12	220621-262873	Predicted membrane proteins, Transporters	Neurotransmitter transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	kidney: 77.6;retina: 95.9	Cell type enriched	Detected in some	6	Proximal tubular cells: 261.2	Cancer enriched	Detected in some	18	renal cancer: 32.1	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	RPTEC TERT1: 10.0;SuSa: 3.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036449, HPA052726			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol						Mitochondria	Nucleoplasm, Nucleoli, Cytosol	HPA036449: AB_2675130, HPA052726: AB_2681927	unprognostic (8.45e-3)	unprognostic (4.20e-1)	unprognostic (5.44e-2)	unprognostic (1.64e-5)	unprognostic (1.13e-1)	unprognostic (8.02e-2)	unprognostic (1.32e-2)	unprognostic (1.30e-1)	unprognostic (1.75e-1)	unprognostic (2.15e-1)	unprognostic (7.21e-4)	unprognostic (2.93e-1)	unprognostic (1.25e-3)	unprognostic (3.79e-2)	unprognostic (2.62e-1)	unprognostic (6.23e-2)	unprognostic (1.91e-1)	0.6	0.5	3	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0	1.8	0.5	0.9	0.4	4.2	0.5	1	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0	4.9	0	0.5	0.5	0	0.4	0	0	0	0.6	0.9	0.3	0	0	0.1	0.3	0.1	0.2	0.2	0.2	0	0	0	0.5	0	0	0.5	0.1	0	0.1	0	0	0	0.4	0.1	0	0.6	0	0	0	1.3	0.2	0.1	0	0	0.3	0	0.5	0.4	0.4	0.5	0	0	0.2	0.1	0	0	0.2	0	0.1	10	0.1	0.1	0	0.1	0	0.9	3.7	0	0	0.3	0.2	1	0	0.4	1.4	0.9	0	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0	0.4	0.9	0	0	0.6	0	0	0	0.3	3	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0	1.1	0.5	0	0	0.2	1.3	0	1.4	0	17.4	2	0	41.4	0	1.1	0	0	0	0	0	0.2	0	0	19.7	0	0	0	0.6	0.6	0.4	0.3	0	0	0	0	0	0	0	0	261.2	0.8	0	0	0.5	0.5	0	0.2	0	0	0	Proximal tubular cells
FMO1		ENSG00000010932	Flavin containing monooxygenase 1	Q01740	1	171248471-171285978	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	kidney: 70.4	Cell type enriched	Detected in some	12	Proximal tubular cells: 142.2	Cancer enriched	Detected in many	8	renal cancer: 18.0	Not detected	Not detected			Cell type enriched	Detected in single	36	naive B-cell: 3.5	Lineage enriched	Detected in single	36	B-cells: 3.5	Cell line enriched	Detected in some	7	HSkMC: 22.0	Low region specificity	Detected in all			Low region specificity	Detected in single			HPA078132	Approved											HPA078132: 	unprognostic (1.04e-1)	unprognostic (1.05e-2)	unprognostic (5.87e-2)	unprognostic (1.34e-1)	unprognostic (5.32e-3)	unprognostic (1.89e-2)	unprognostic (1.04e-1)	unprognostic (4.04e-1)	unprognostic (9.16e-2)	unprognostic (9.03e-2)	unprognostic (1.36e-2)	unprognostic (2.23e-1)	prognostic favorable (2.81e-4)	unprognostic (6.49e-4)	unprognostic (1.40e-1)	unprognostic (3.58e-1)	unprognostic (1.37e-1)	3.4	3.6	0.1	0.1	0.3	0	5.6	0.1	0.4	5.6	0.8	0.3	0.8	0	2.5	3	5	3.3	1.8	0.9	0.1	0	70.4	1	0.8	0.1	0.1	0.1	5.9	2.4	0.1	1.1	0.8	0.2	1.1	0	4	4.2	1.5	0.1	4	14.4	1.5	0.1	0.1	0.5	1.6	0.1	1.8	1.7	5.3	10.3	1.4	1.1	3.5	0	0	0	0	0	0	0	0	0	0	2.9	1.1	0	0	1.2	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	22	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0.1	0.3	0.1	0.4	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.4	2.9	0	8.7	5.1	0	0	3.5	0	0.2	11.6	0	0.6	0	0	0	0	0	8.8	0.1	0	0	0.3	0	0	0	0	1	10	0	1.7	0	0.3	0	0	0	2.5	142.2	0	6.5	1.4	0	0	1.9	0.7	0	0	0	Proximal tubular cells
SLC7A9	CSNU3	ENSG00000021488	Solute carrier family 7 member 9	P82251	19	32830509-32869766	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Amino-acid transport, Transport		Cystinuria, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 63.3;kidney: 26.4	Cell type enriched	Detected in some	5	Proximal tubular cells: 55.5	Group enriched	Detected in some	7	liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	17	BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0	Not detected	Not detected			Low region specificity	Detected in all			HPA042591	Enhanced											HPA042591: AB_10962500	unprognostic (4.12e-2)	unprognostic (5.40e-2)	unprognostic (6.19e-2)	unprognostic (3.37e-3)	unprognostic (1.69e-1)	unprognostic (1.54e-1)	unprognostic (4.17e-2)	unprognostic (3.87e-2)	unprognostic (1.49e-1)	unprognostic (1.78e-1)	unprognostic (1.24e-1)	unprognostic (2.39e-1)	unprognostic (9.69e-2)	unprognostic (5.97e-2)	unprognostic (3.20e-1)	unprognostic (4.94e-3)	unprognostic (5.10e-5)	0.1	0	0.1	0.3	0.2	0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11	0.1	0.1	0.1	0.1	0.2	0.1	0	0.3	0.2	0.1	0.3	0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0.1	4.9	0	0	0	0	11.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	11	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0.5	0	0.1	0	0.1	0	0	0	0.1	0	0	0	0	0.1	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0.8	0.3	0	2.7	0	5.2	3.9	0.1	1.7	0	0.7	0	0	0	6.6	6.5	0	0	0	10.5	0.2	0	0	0	0	0	0.6	0	0	0	0	0.5	0.5	0	0	55.5	1.3	0	0	0	0.2	0	0	0	0	0	Proximal tubular cells
SLC13A1	NAS1, NaSi-1	ENSG00000081800	Solute carrier family 13 member 1	Q9BZW2	7	123113531-123199986	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Sulfate transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	kidney: 67.5	Cell type enriched	Detected in some	17	Proximal tubular cells: 400.4	Cancer enriched	Detected in single	219	renal cancer: 10.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		BEWO: 1.0	Region enriched	Detected in single	5	cerebellum: 0.9	Low region specificity	Detected in all			HPA053615, HPA062714	Enhanced											HPA053615: AB_2682207, HPA062714: AB_2684846											unprognostic (1.86e-1)		prognostic favorable (8.95e-5)	unprognostic (1.71e-1)	unprognostic (3.76e-1)			0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	4.2	0	0	0	67.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0.2	0	0.2	0	0	1	0.9	0	0.1	0	0	0.1	0.6	0	0	0	0	0	0	0	0.5	0	0.5	0.1	0.3	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.2	0.7	0.1	0	0	0	0.2	0.3	0	0.4	0.6	0	0	0	0	0	0	0	0.4	0.5	0	0.1	0	0.8	0.1	0.6	0.2	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	7	0	0	23.2	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	400.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
NOX4	KOX, KOX-1	ENSG00000086991	NADPH oxidase 4	Q9NPH5	11	89324356-89498187	Predicted membrane proteins, Transporters		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	9	kidney: 65.2	Cell type enriched	Detected in some	6	Proximal tubular cells: 119.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8	Not detected	Not detected			Low region specificity	Detected in many			HPA015475			Approved	Nucleoplasm						Nucleoplasm		HPA015475: AB_1854574	unprognostic (2.91e-2)	unprognostic (1.08e-1)	unprognostic (1.74e-3)	unprognostic (6.58e-3)	unprognostic (1.92e-1)	unprognostic (2.33e-1)	unprognostic (8.83e-3)	unprognostic (8.95e-3)	unprognostic (3.80e-1)	unprognostic (6.88e-2)	unprognostic (1.56e-2)	unprognostic (1.73e-1)	prognostic favorable (6.14e-4)	unprognostic (1.99e-4)	unprognostic (9.71e-2)	unprognostic (5.69e-2)	unprognostic (3.03e-3)	7.5	0.6	0.2	0.6	0.6	0.3	6.5	0.3	0.5	1.2	0.9	1.1	0.4	0.3	7.3	2.5	1.5	0.8	1.3	6.9	0.6	0.2	65.2	0.3	1.2	0.3	0.3	0.2	0.7	1.1	3.8	0.8	1.7	1	2.6	0.4	0.8	2.6	0.9	5.1	1.1	0.5	3.5	1.2	0.4	0.4	1	0	0	1.7	1.7	0.4	2.1	1.1	0.4	0.3	1.7	0.3	0.8	0.3	0	0	0	1.1	0	0	0	0	1.8	0.1	0.3	0.1	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0.1	0	0	0.4	0	0	0	8.5	15.6	0	0	0.1	0	0	0	0	3.7	0	0	0	0	0	1.1	0	0	3.1	0	0	0.2	4.3	0.3	0	34.8	0.1	2.7	0	2.4	0	0	0	0	0	0	1.6	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0	0.4	0.3	0.3	1.7	0.8	0.2	0.3	0.2	0	0.2	0.6	0.3	0.5	0.6	0.2	0.3	0.2	1	0	0	0	0	0	0.6	4.1	1.1	0	0	0	10.4	5.9	1.2	13.3	0	0.8	1.1	0	0	0	0.6	1.1	0.1	0	0	0.2	0	0	3.7	0	0.4	0.3	0	0	0	0	3.7	0.1	0	1.1	119.8	19.3	0	0.3	0.5	0.1	0.3	2.1	0	0	0	Proximal tubular cells
RAB11FIP3	eferin, KIAA0665, Rab11-FIP3	ENSG00000090565	RAB11 family interacting protein 3	O75154	16	425619-523011	Cancer-related genes, Predicted intracellular proteins	Cell cycle, Cell division, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		kidney: 70.5	Cell type enriched	Detected in many	14	Proximal tubular cells: 333.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in all							Low region specificity	Detected in all			HPA028088, HPA028631, HPA030086	Enhanced		Enhanced	Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria		Yes	No			Vesicles, Centriolar satellite	Nucleoplasm, Cytokinetic bridge, Mitochondria	HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596	unprognostic (6.65e-2)	unprognostic (1.84e-2)	unprognostic (1.51e-1)	prognostic favorable (1.22e-4)	unprognostic (2.87e-2)	unprognostic (1.85e-1)	prognostic unfavorable (9.87e-5)	unprognostic (6.71e-2)	unprognostic (4.74e-1)	unprognostic (9.66e-2)	prognostic favorable (3.16e-5)	unprognostic (1.12e-1)	prognostic favorable (7.99e-4)	unprognostic (1.39e-1)	unprognostic (1.77e-1)	unprognostic (1.58e-1)	unprognostic (1.44e-1)	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9	13.4	11.9	11	8.2	9.5	11.3	14	18.7	12.1	70.5	12.2	10.5	8.1	12	18	13.4	22.2	22.4	14.6	10	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.2	9.8	8.6	14.5	9.5	8.5	8.5	8	7.8	5.6	7.5	2.1	12.3	10	12.4	6.9	4.6	6.1	9	2.7	9.1	8.7	5.5	9.5	21.7	15.5	5.5	6.9	9.1	6.2	8	7	9.1	11.9	8.5	2.8	4.9	9.8	13.7	8.9	10.9	8.2	3.2	4.2	18.5	7.8	3.2	7.8	2.7	10.2	9.5	8.7	10.7	5.4	3.5	5.9	10.2	19.2	11.4	7.6	10.6	5.6	6.8	5.3	14.5	4.3	3.9	8.4	0	0.1	0	1.5	0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0	0.8	0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12	18	10.6	11.9	3	1.7	3.4	0.4	3.3	8.2	11.7	7.6	4	6.8	5.2	5.9	0.8	23.2	1.4	1	2.5	6.4	0	1	0.1	2.3	1.1	1.1	14.1	0.7	20.6	2.9	19.6	5.1	1.6	0.6	1.2	0	0	2.7	6.1	1.6	1.7	1.8	333.9	7.1	6.5	2.1	2.7	3	1.9	0.7	2.6	4.1	0.3	Proximal tubular cells
SMIM24	C19orf77, HSPC323	ENSG00000095932	Small integral membrane protein 24	O75264	19	3473986-3480542	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 160.8;intestine: 204.2;kidney: 76.9	Cell type enriched	Detected in many	6	Proximal tubular cells: 1384.0	Cancer enhanced	Detected in many		renal cancer: 78.4	Low region specificity	Detected in single			Cell type enhanced	Detected in many		NK-cell: 8.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7	Low region specificity	Detected in many							HPA045046, HPA056027	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA045046: AB_10964444, HPA056027: AB_2683012	unprognostic (2.18e-4)	unprognostic (4.63e-1)	unprognostic (5.68e-2)	unprognostic (9.60e-2)	unprognostic (1.93e-1)	unprognostic (6.23e-2)	unprognostic (1.03e-1)	unprognostic (1.61e-1)	unprognostic (1.64e-1)	unprognostic (2.85e-1)	unprognostic (2.84e-1)	unprognostic (1.07e-1)	prognostic favorable (4.13e-10)	unprognostic (1.68e-2)	unprognostic (2.14e-1)	unprognostic (8.36e-2)	unprognostic (3.11e-2)	0.2	0.1	0.7	0.6	0.9	7	0.3	0.2	2.2	0.2	137	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0	0.9	0.2	0.3	0.3	2	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3	0	8.6	2.1	1.1	0	0	0	0	0	0	0.7	0	0	0.1	0	42.4	0.1	0	2.2	0	0.1	0	0	0	0	0	0	20	0.2	31.7	0	1.7	0.5	0	0	0	0	0	0	2.9	0.3	0	0	0	30.2	4.2	0	50.3	0	16.6	0	1.1	0.4	0	0.4	0.6	0	0	0.4	0.1	0	0.5	0	0	0.1	0.3	0	0	0	1.7	0	23.7	0	3	0	0	0.1	0	0	3.2	0	0	0.1	0.6	0.7	1.7	0	8.6	0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3	0	0	1.7	0.1	0	12.1	0.2	229.3	0	0	55.8	25.5	0	202.2	3.9	5	0	64.6	23.3	11.3	0.1	0	0.3	1.1	8.5	0.1	0	133.5	0.6	0.8	11.2	0.3	0	0	1	34.7	2.7	11.1	51.8	0	1384	32.6	0	0	0.7	0.4	0	0	1	35.7	0.2	Proximal tubular cells
MIOX	ALDRL6	ENSG00000100253	Myo-inositol oxygenase	Q9UGB7	22	50486784-50490648	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	43	kidney: 136.7	Cell type enriched	Detected in some	5	Proximal tubular cells: 1814.0	Cancer enriched	Detected in many	16	renal cancer: 56.0	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 21.8;Hep G2: 4.9;Karpas-707: 11.6;U-266/70: 7.0	Not detected	Not detected			Not detected	Not detected			HPA039451, HPA039562	Enhanced											HPA039451: AB_2676513, HPA039562: AB_2676574	unprognostic (2.11e-1)	unprognostic (4.32e-2)	unprognostic (2.22e-2)	unprognostic (1.30e-2)	unprognostic (9.83e-2)	unprognostic (5.25e-2)	unprognostic (1.61e-2)	unprognostic (3.84e-3)	unprognostic (2.84e-1)	unprognostic (4.72e-2)	unprognostic (1.85e-2)	unprognostic (9.83e-2)	prognostic favorable (2.60e-6)	unprognostic (1.77e-1)	unprognostic (1.50e-1)	unprognostic (1.36e-2)	unprognostic (2.23e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.8	0.1	0.1	0	136.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.4	2.7	0.1	0.1	0.1	0.1	1.3	0.6	3.1	0.7	0.4	1.4	0.4	0	0	0.1	0.3	0.2	0.1	1.8	0.2	0	0	0.1	0.1	0.3	0.1	0.6	0.4	0	0.1	0.1	0	0	21.8	0	0.1	0.3	4.9	2.9	0	0.2	0	0	0.1	0.4	0	0	1	0.1	11.6	0	1.1	0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.3	0.1	0.1	0.3	0	0	0.4	0.4	0	1.2	0	0	0.5	0.1	0	7	0.6	0.3	0.1	0	0.2	3.1	0.4	0.6	0.5	0.3	0.2	1.3	0.5	1.4	0.1	0.9	0.5	0.6	1.8	0.4	0.7	0.6	0.4	0.4	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	1.7	2.4	0.8	0.7	0.5	0	0	0	0	94.2	0	0	359.8	0	0	0.1	0	0	0.8	0.1	0.2	0.4	0	0.2	0.1	0	1.2	0.6	0	0	0	0.8	0	0	0.4	0.2	0	0	0	1814	0.2	0	0.2	0.1	0.4	0.1	0.2	0.9	0	0.6	Proximal tubular cells
DHDH	HUM2DD	ENSG00000104808	Dihydrodiol dehydrogenase	Q9UQ10	19	48933682-48944969	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 32.4;kidney: 18.0	Cell type enriched	Detected in many	5	Proximal tubular cells: 56.2	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		basophil: 5.8;naive CD4 T-cell: 4.8	Group enriched	Detected in many	31	granulocytes: 5.8;T-cells: 4.8	Cell line enhanced	Detected in many		JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0					Low region specificity	Detected in all			HPA044131	Approved		Approved	Nucleoplasm,Actin filaments						Nucleoplasm, Actin filaments		HPA044131: AB_10966968	unprognostic (1.54e-1)	unprognostic (2.72e-2)	unprognostic (1.07e-1)	prognostic unfavorable (9.91e-4)	unprognostic (3.33e-3)	unprognostic (1.45e-1)	unprognostic (5.81e-6)	unprognostic (1.56e-2)	unprognostic (5.88e-2)	unprognostic (4.96e-2)	unprognostic (3.30e-2)	unprognostic (5.08e-2)	prognostic favorable (3.15e-4)	unprognostic (2.93e-2)	unprognostic (1.23e-1)	unprognostic (1.67e-1)	unprognostic (1.54e-1)	0.3	0.5	1.5	0.1	2.1	0.1	0.2	1.8	1.5	0.1	8.2	0.2	0.1	10.6	0.2	0.4	0.8	0.3	0.8	0.1	2.7	2	18	0.7	1.9	0.2	0.4	0.4	0.5	0.4	0.2	2.1	1.3	0.6	3.5	0.1	1.2	0.8	0.2	0.3	0.2	32.4	0.1	0.9	1.8	0.7	2.8	0.1	0.4	0.1	0.5	0.7	1.1	0.3	0.1	0	5.8	0	0	4.8	0.5	2.8	0	0.2	1.4	0.8	0.6	1.1	0	0.4	0.5	1.4	2.7	2.2	0	0.5	0	1.8	0.8	0.9	2	0.9	1	2.2	3.9	0.9	1	0	0	0.9	0.5	0.2	1.1	0	0.7	0	6.3	1.2	0.4	0	0.6	0	0.2	0.6	4	1.8	1.4	0.2	1.9	0.3	0.9	4.2	2.3	0.5	0.3	0.9	0.3	1.9	0.1	0	0	1.7	0.6	0.1	6.4	5	1.6	1.3	0	0.4	5.8	0	0.9	1.6	0	0.8	0	1.6	0.7	0	0.1	4.8	3.1	0.1	0	0	0	1.2	0.5	1.5	2.1	1.8	1.5	2.7	2	0.4	0.4	0.6	0.1	3	5.4	0	2.6	0.7	1.3	0.4	0	0	4.5	3.5	0	0.1	8.3	1.3	0.5	0.6	1.7	0	0.3	0.1	0.5	5.2	1.1	0	10.9	0	0	0	0.8	1.4	0	0	0	0	0.7	1.5	1.2	2.9	0	56.2	4.3	0	0.1	0	0.6	0.1	0.1	0	0.6	2.6	Proximal tubular cells
CUBN	gp280, IFCR, MGA1	ENSG00000107611	Cubilin	O60494	10	16823964-17129831	Disease related genes, Predicted intracellular proteins	Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport	Receptor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	intestine: 28.9;kidney: 79.7	Cell type enriched	Detected in many	12	Proximal tubular cells: 301.3	Cancer enriched	Detected in some	15	renal cancer: 24.3	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AN3-CA: 18.2;ASC TERT1: 4.6;SK-MEL-30: 3.4;WM-115: 6.9	Low region specificity	Detected in some			Not detected	Not detected			HPA004133, HPA043854	Enhanced				Intracellular and membrane				240000			HPA004133: AB_2732398, HPA043854: AB_2732510	unprognostic (1.75e-1)	unprognostic (2.35e-1)	unprognostic (2.12e-3)	unprognostic (8.61e-4)	unprognostic (9.54e-2)	unprognostic (2.78e-2)	unprognostic (2.88e-2)	unprognostic (7.03e-2)	unprognostic (1.24e-1)	unprognostic (7.16e-2)	unprognostic (1.98e-2)	unprognostic (2.47e-1)	prognostic favorable (1.12e-4)	unprognostic (6.24e-3)	unprognostic (1.97e-1)	unprognostic (2.00e-1)	unprognostic (1.93e-1)	0.3	0.3	0.3	0.3	0.6	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.3	0	0.4	11.5	0.3	1.6	0.3	0.3	0.3	0.3	79.7	0.3	0.3	0.4	0.3	0.3	2	0.3	0.6	1.7	1.1	0.3	0.6	0.1	0.3	0.3	0.3	0.3	0.3	28.9	0.3	0.3	0.5	0.1	1.2	0.3	0.3	3.1	0.3	0.3	0.3	0.3	0.8	1.2	0.9	0.2	0.6	1.4	0	0	0.1	1.8	18.2	0.6	4.6	0.1	0.1	0.1	0.1	0.1	2.1	0	0	0.1	0.9	1.2	0	0	0.2	0.1	0.4	0	0.2	0.2	0	0.1	0	0.1	0.6	0	0.6	0.2	0.7	1.8	1	0.2	0.3	0.2	0	0.3	0.3	0.3	0	0.2	0.1	0.4	0	0.6	0	0	0.5	0	0	3.4	0.1	0	0.1	1.8	0.2	0.2	0.3	0.2	0.6	0.1	0	0.5	0.1	6.9	0.9	0.2	0	0.8	0	1	0.4	0.4	0.2	0	0.8	0.8	1.4	0.6	0.6	0	1.2	0.7	0	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	1	0	0.4	0.5	0.9	1.1	0	2.7	5.7	5.2	2	0	11.6	0	25.3	2.7	0	0	0.2	0	0.6	0.4	0	0	0.1	0	0	0.6	0.8	25.4	2.6	0.4	6.8	0	0.3	8.7	0.1	0	1.1	301.3	3.7	0	1.2	0.7	0.2	0.6	0.1	0.5	0	0.1	Proximal tubular cells
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15572353-15585110	Enzymes, Predicted intracellular proteins	Putrescine biosynthesis, Spermidine biosynthesis	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 21.3;kidney: 54.7;liver: 66.1	Cell type enriched	Detected in many	7	Proximal tubular cells: 278.6	Group enriched	Detected in all	5	colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1	Low region specificity	Detected in single			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	B-cells: 4.6;T-cells: 10.5	Cell line enhanced	Detected in many		CACO-2: 19.0;Hep G2: 46.0;RPMI-8226: 11.4	Low region specificity	Detected in many			Not detected	Not detected			HPA026443, HPA028321	Enhanced								250000			HPA026443: AB_1844644, HPA028321: AB_10600779	unprognostic (2.27e-2)	unprognostic (3.45e-1)	unprognostic (1.79e-3)	unprognostic (3.60e-2)	unprognostic (8.72e-2)	unprognostic (6.66e-3)	unprognostic (9.48e-2)	unprognostic (1.19e-2)	unprognostic (2.06e-2)	unprognostic (2.37e-2)	unprognostic (1.13e-2)	unprognostic (2.35e-1)	prognostic favorable (5.13e-4)	unprognostic (4.43e-3)	unprognostic (2.44e-1)	unprognostic (1.33e-1)	unprognostic (2.45e-2)	0.7	0.8	0.7	2.8	0.5	0.1	0.4	0.2	1	0.2	14.9	0.3	0	7.1	0.3	1.2	0.5	0.2	3.6	0.3	0.6	0.8	54.7	66.1	0.2	1.3	0.7	0.3	0.2	1.1	1.3	0.4	0.2	0.6	0.3	2.8	0.1	9.6	0	12.3	0.2	21.3	0.1	0.3	1	0.5	0.5	0.1	1	0.3	1.7	1.5	0.4	0.2	4.6	0.4	1.4	0.3	0.4	10.5	2.8	4	3.2	0.2	0.1	0	0.4	0.1	0.7	0.7	0.4	0.2	19	2.6	0	0.1	0.5	0	0	0	0	0.5	3.9	0	2.5	2.7	46	0.5	2	0	0.5	0.2	1.3	0	0.3	0.4	0	0	5.4	1	4.3	0	1.9	4.3	3.2	1.8	0	0	11.4	0.1	1	0.7	0.6	5.5	0.2	0.6	0.2	0.7	3.8	0.5	0.1	0.1	1	0	0.1	3	2.6	0.2	0	0	0.9	0.3	0.2	2.4	0.3	3.1	4.6	5.7	3	0.2	3.2	10.5	5.9	1.4	0.4	0.2	0.4	7.1	2.8	0.7	0.5	0.2	1	0.6	0.8	0.7	0.3	0.6	0.1	0	0	3.2	1.5	0.2	1.2	0.4	5.1	1.4	0	3.5	0	0.7	26.6	0.8	6.9	0.1	12.9	0	0.8	0.7	0.7	0.9	0	38.9	0.9	3.2	1.2	1.8	2.2	3.6	0.3	0.4	1.7	1	6.7	0.8	2	3.5	0	278.6	1.7	0	0.4	1.6	2.9	0.5	0.7	5	13.8	2.6	Proximal tubular cells
PEPD		ENSG00000124299	Peptidase D	P12955	19	33386950-33521794	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Collagen degradation	Dipeptidase, Hydrolase, Metalloprotease, Protease	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		intestine: 92.9;kidney: 106.0	Cell type enriched	Detected in many	5	Proximal tubular cells: 1020.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015599, HPA072045	Enhanced		Approved	Nucleoplasm					1000000000	Nucleoplasm		HPA015599: AB_1855192, HPA072045: AB_2732194	unprognostic (1.39e-1)	unprognostic (2.62e-2)	unprognostic (2.27e-1)	unprognostic (4.01e-2)	unprognostic (2.98e-1)	unprognostic (6.77e-2)	unprognostic (2.82e-1)	unprognostic (3.64e-2)	unprognostic (3.96e-1)	unprognostic (5.10e-2)	unprognostic (1.11e-2)	unprognostic (1.99e-1)	prognostic favorable (6.50e-9)	unprognostic (4.38e-2)	unprognostic (1.99e-1)	unprognostic (1.65e-1)	unprognostic (1.29e-1)	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8	10.8	9.1	106	48.6	11.1	10.6	16	7.7	12.6	9	9.6	12.5	10.4	13	9.2	6.6	13.3	9.6	9	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.3	36.3	10.7	17.3	45.7	17.6	24.8	11.9	24.4	15.2	17.3	31.6	11.8	5.4	17.8	29.8	11.7	3.5	15.4	9.7	12.5	15.4	15.2	34.7	7.4	32.1	31.3	10.1	42.1	21.7	9.2	13.8	8.6	11.2	20.3	10.7	6.6	15.8	16.5	16.3	7.7	3.4	14.7	26.6	14.8	15.2	14.6	15	13.1	35.3	13.2	33.8	22.2	11	17.9	9.4	7.6	11	16.9	14.7	15.9	19	13.7	14.5	21.5	4.8	15.7	14.6	20.9	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16	7.7	13	11.5	20.8	24.3	20.2	26.1	17.2	33.9	11.7	43.3	26.8	11.4	69.8	3.9	19.3	167.5	63.4	7.6	44.9	37.6	0	38.3	59.7	34.6	21.4	55.5	161.7	189.6	58.8	16.6	35	46.9	8.9	45.8	63.2	64.1	131.7	14.5	69.3	37.3	28.5	57	1020.8	23.8	38.8	38.8	11.4	48.3	17.8	25.4	31	16.7	18	Proximal tubular cells
SLC17A3	NPT4	ENSG00000124564	Solute carrier family 17 member 3	O00476	6	25833066-25882286	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	kidney: 62.3	Cell type enriched	Detected in some	10	Proximal tubular cells: 127.1	Cancer enriched	Detected in some	17	renal cancer: 57.0	Not detected	Not detected			Group enriched	Detected in some	6	gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6	Lineage enriched	Detected in single	19	T-cells: 1.9	Cell line enriched	Detected in single	217	RPTEC TERT1: 51.8	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (5.31e-3)				unprognostic (1.56e-2)		unprognostic (2.51e-1)	unprognostic (4.65e-2)			unprognostic (5.05e-2)	unprognostic (1.88e-1)	unprognostic (1.07e-1)	unprognostic (2.34e-1)	unprognostic (1.34e-1)	unprognostic (4.49e-1)		0.1	0.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0	62.3	13.6	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1.9	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	51.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	1.9	0	1.6	0.2	0	0	0	0.1	0	0	0	0	0	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0.5	0.2	0	0	0.2	0	0	0	1.8	0	0	6.6	0	0.9	0	0	0	0	0	0	0.1	0	12.4	0	0	0	1.3	0	0.4	0	0	0	0	0	0	0	0	0	127.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SLC17A1	NAPI-1, NPT1	ENSG00000124568	Solute carrier family 17 member 1	Q14916	6	25782897-25832059	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	56	kidney: 67.6;liver: 17.9	Cell type enriched	Detected in some	4	Proximal tubular cells: 44.6	Group enriched	Detected in some	150	liver cancer: 7.6;renal cancer: 19.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	389	RPTEC TERT1: 38.8	Not detected	Not detected			Low region specificity	Detected in all			HPA050513			Approved	Golgi apparatus						Golgi apparatus		HPA050513: AB_2681152			unprognostic (6.98e-2)		unprognostic (2.99e-1)		unprognostic (1.03e-1)				unprognostic (1.26e-1)		unprognostic (2.71e-3)	unprognostic (1.32e-1)	unprognostic (2.37e-1)	unprognostic (4.74e-1)		0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	67.6	17.9	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	38.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	1.8	0	0	0	0	10.9	0	0	0	0	0	0	0	0	9	0	0	0	0	0	1.3	0.3	0	0	0	0	0	0	0	0.4	44.6	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
BBOX1	BBH, BBOX, G-BBH, gamma-BBH	ENSG00000129151	Gamma-butyrobetaine hydroxylase 1	O75936	11	27040725-27127809	Enzymes, Predicted intracellular proteins	Carnitine biosynthesis	Dioxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	kidney: 139.4;liver: 39.3	Cell type enriched	Detected in many	5	Proximal tubular cells: 1023.7	Group enriched	Detected in many	6	glioma: 23.7;renal cancer: 59.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	hTCEpi: 16.2;RPTEC TERT1: 10.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA007600, HPA027823	Enhanced	Approved	Uncertain	Vesicles,Actin filaments					25000	Vesicles	Actin filaments	HPA007600: AB_1845284, HPA027823: AB_10602394	unprognostic (9.96e-3)	unprognostic (1.80e-2)	unprognostic (8.17e-2)	prognostic unfavorable (6.65e-4)	unprognostic (7.03e-2)	unprognostic (6.66e-2)	unprognostic (7.05e-3)	unprognostic (1.13e-2)	unprognostic (3.03e-1)	unprognostic (6.89e-2)	unprognostic (2.03e-2)	unprognostic (1.60e-1)	prognostic favorable (1.45e-5)	unprognostic (1.71e-2)	unprognostic (2.70e-1)	unprognostic (3.22e-1)	unprognostic (1.73e-3)	0.9	0.5	9.2	0.5	7.1	0.5	8.2	3.9	7.5	1.5	0.6	4.9	0.1	0.5	0.6	3.6	5.7	3.8	3.6	0.5	7.9	6.3	139.4	39.3	0.6	0.6	10.9	4.3	0.5	0.8	0.5	8.3	1.3	9.2	0.7	0.5	0	2.2	2	0.6	16.4	0.5	0.5	7.1	0.5	0.6	0.6	5.8	0	8.9	1.6	0.7	0.6	3.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	1.4	0	0	0	0	0	0	0	0	0	0.7	0	1	16.2	0	0	3.2	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0	0	10	0	0	0	0.5	2.5	0	0.2	0	0	0	0	0	0.1	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.2	7.1	3.9	7.5	7.9	6.3	10.9	4.3	9.2	5.8	0	1.1	0	5.5	7.2	0	0	17.8	6.7	2.3	43.6	0	0.1	189	0.3	0.7	0	0	0	0	0	0.3	0.1	0	25.4	0	0	0	0.6	1.2	1.1	0	0	1.7	0	0	11.3	0.1	0	0.4	1023.7	0.3	0	0.4	0	0.1	31.2	0.2	0	0	2.2	Proximal tubular cells
SLC34A1	NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2	ENSG00000131183	Solute carrier family 34 member 1	Q06495	5	177379235-177398848	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	79	kidney: 94.5	Cell type enriched	Detected in some	16	Proximal tubular cells: 128.7	Cancer enriched	Detected in single	12	renal cancer: 1.8	Not detected	Not detected			Cell type enhanced	Detected in single		naive CD8 T-cell: 1.1	Lineage enriched	Detected in single	12	T-cells: 1.1	Group enriched	Detected in some	12	HEL: 6.7;U-937: 4.4	Not detected	Not detected			Not detected	Not detected			HPA051255, HPA077175	Approved		Approved	Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol		Yes				Nuclear speckles, Plasma membrane	Nucleoplasm, Mitotic spindle, Cytosol	HPA051255: AB_2681409, HPA077175: 	unprognostic (1.17e-1)	unprognostic (3.33e-3)	unprognostic (1.49e-1)	unprognostic (3.49e-2)		unprognostic (1.56e-3)	unprognostic (2.28e-1)	unprognostic (4.50e-2)	unprognostic (4.43e-3)	unprognostic (1.91e-1)	unprognostic (1.14e-1)	unprognostic (5.95e-2)	unprognostic (1.23e-3)	unprognostic (1.38e-1)	unprognostic (2.01e-1)	unprognostic (1.28e-2)	unprognostic (4.66e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	94.5	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.6	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0.1	0.4	0	0.1	0	0.2	0	6.7	0	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	4.4	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.9	0	0	0	7	0	0	8.3	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	128.7	0	0	0	0	0	0.5	0	0	0	0	Proximal tubular cells
RIDA	HRSP12, P14.5, PSP, UK114	ENSG00000132541	Reactive intermediate imine deaminase A homolog	P52758	8	98102344-98117241	Enzymes, Plasma proteins, Predicted intracellular proteins		Hydrolase, RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	9	kidney: 81.4;liver: 248.6	Cell type enriched	Detected in many	5	Proximal tubular cells: 1135.9	Cancer enhanced	Detected in all		liver cancer: 162.2	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		OE19: 61.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA022856, HPA023489	Enhanced								5700000			HPA022856: AB_1858253, HPA023489: AB_1858252	unprognostic (1.67e-2)	unprognostic (3.73e-1)	unprognostic (1.29e-1)	unprognostic (1.10e-1)	unprognostic (4.16e-1)	unprognostic (2.20e-2)	prognostic favorable (9.61e-6)	unprognostic (6.08e-2)	unprognostic (1.13e-1)	unprognostic (3.15e-1)	unprognostic (2.81e-1)	unprognostic (4.46e-1)	unprognostic (1.55e-1)	unprognostic (1.73e-1)	unprognostic (2.04e-1)	unprognostic (2.08e-2)	unprognostic (1.51e-2)	8.3	9.4	16.8	2.5	18.8	1.6	4.2	5.6	11.6	2.6	4.7	4.5	2.7	5.8	2.1	4.8	2.8	2.2	4.3	5.2	11.7	12.5	81.4	248.6	2.2	2.1	19.1	9.5	4.6	5.2	3.5	1.8	2.4	11.8	4	4.8	2.3	3.2	2.7	6.8	2.3	4.2	2.5	7.9	1.8	4.6	3.3	9.5	0.6	3.2	3.5	2.6	3.2	1.8	12.1	10	5	8.3	8.4	12.8	7.1	13.9	12.1	9.8	11.9	22.2	17.3	10.7	12.9	9.1	8.6	10.4	16.4	9.4	19.8	16.6	9.4	11.5	9.9	21.4	18.3	17.5	6.9	9.2	14.4	8.2	17.5	10.1	5.3	2.3	14.9	6.3	12.1	13.3	10.9	11.1	21.4	25.6	4.3	11.5	18.1	11.2	14.4	15.5	61.2	22.1	13	7.1	5.7	20.8	10	10.6	5.3	8.2	5.7	8.9	13	14.5	7	6.7	6.7	4.2	11.3	5.1	10.3	14.1	9.7	11.7	11.2	4.3	0.1	8.3	5	6.5	7	8.3	12.1	9.4	9.5	10	9.5	12.2	12.8	1.5	8.4	7	7.6	12.3	7.1	16.8	18.8	5.6	11.6	11.7	12.5	19.1	9.5	11.8	9.5	23.8	15.3	0	0	0	0	0	0	10.7	3.4	45.4	0	25.5	242.1	13.4	0	0	0	0	7.5	23.7	0	0	2.3	0	21.3	0	0	0	0	0	0	2.2	0	10	0	0	14.6	0	0	1135.9	0	0	0	0	0	0	12	0	0	0	Proximal tubular cells
ACY3	ACY-3, HCBP1, MGC9740	ENSG00000132744	Aminoacylase 3	Q96HD9	11	67642555-67650659	Enzymes, Predicted intracellular proteins	Host-virus interaction	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 72.2;kidney: 28.9	Cell type enriched	Detected in many	6	Proximal tubular cells: 163.1	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in many		non-classical monocyte: 21.1	Group enriched	Detected in many	6	dendritic cells: 5.9;monocytes: 21.1	Cell line enhanced	Detected in some		CACO-2: 6.1;CAPAN-2: 9.5;Daudi: 34.5;OE19: 9.6;RPMI-8226: 6.0	Low region specificity	Detected in all							HPA039219, HPA048187	Enhanced											HPA039219: AB_10671872, HPA048187: AB_2680306	unprognostic (8.37e-3)	unprognostic (1.29e-1)	unprognostic (1.04e-1)	prognostic favorable (4.80e-4)	unprognostic (1.07e-1)	unprognostic (1.99e-2)	unprognostic (1.38e-2)	unprognostic (1.43e-1)	unprognostic (7.37e-4)	unprognostic (2.44e-3)	unprognostic (1.15e-1)	unprognostic (3.21e-1)	unprognostic (2.63e-3)	unprognostic (1.07e-1)	unprognostic (8.24e-2)	unprognostic (2.68e-2)	unprognostic (1.48e-3)	0.1	0.1	3.4	1.8	5.5	0.6	0.5	0.8	7.8	5.5	13	15.3	0.2	38.2	0.3	2.1	0.7	0.4	6.1	0.1	3.1	2.9	28.9	18.3	0.2	3.1	4.6	5.1	0.1	11.2	0	0.3	0.1	7.1	0.4	2.2	0.3	1.2	0.2	0.1	0.1	72.2	0.1	5.2	0.9	5.9	0.1	2.8	0.7	0.2	0	4.2	0.2	0.2	1.1	5.9	0	21.1	2.3	0.9	1.2	0.1	0.8	0	0	0	0	0.2	0	0	0	0	6.1	9.5	34.5	0.4	0	0.9	0	0	0	0	1.3	0	0	0	3.3	0	0	0.2	0	0	0	0	0	0	0.6	0	0.3	0	0	1.2	1.5	0	9.6	0	1.1	0	6	0	0	0	0.1	0.2	0.8	0	0	0	1.7	0.1	0	0	0	0	0	0	0.5	0	3.8	0.3	0	0.5	0	0.1	4.9	0.5	1	0.2	0.1	2.6	1.1	0.9	0.6	0	2.3	21.1	5.9	0	1.2	3.4	5.5	0.8	7.8	3.1	2.9	4.6	5.1	7.1	2.8	0	1.7	6.3	0.1	0	0	0.4	10.2	0	1.2	21	0	0.2	26.6	3.5	0	0	11.8	0	9	0.2	0	0.6	0	17.9	1.7	0	1.2	0	0.3	0	0	0.9	5	0	25.1	0	6.8	5.9	0	163.1	0	0	0	0	0	0.1	0.1	0.9	6.6	0.8	Proximal tubular cells
MYH8	MyHC-peri, MyHC-pn	ENSG00000133020	Myosin heavy chain 8	P13535	17	10390322-10421950	Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	esophagus: 16.5;skeletal muscle: 18.3;tongue: 10.0	Cell type enriched	Detected in some	4	Proximal tubular cells: 29.1	Cancer enhanced	Detected in some		head and neck cancer: 0.7;renal cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	14	HSkMC: 13.1	Low region specificity	Detected in single			Not detected	Not detected			HPA001349, CAB016527	Enhanced											CAB016527: AB_2147291, HPA001349: AB_1079437	unprognostic (5.87e-2)					unprognostic (5.13e-3)		unprognostic (4.12e-2)	unprognostic (1.25e-2)		unprognostic (2.29e-3)	unprognostic (1.08e-1)	unprognostic (5.02e-3)	unprognostic (7.87e-2)	unprognostic (1.61e-1)		unprognostic (3.56e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.5	0	0	0	0	0.1	1.3	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	1.4	0	18.3	0	0	0	0	0.1	0	0.2	0	0.8	0	10	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	3.5	0	0	6.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.1	0	0	0	0.3	0.2	0	0	0	0	0	Proximal tubular cells
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters		Glycosidase, Hormone, Hydrolase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5	Cell type enriched	Detected in some	6	Proximal tubular cells: 99.7	Group enriched	Detected in many	6	prostate cancer: 5.9;renal cancer: 17.8	Region enhanced	Detected in some		pons and medulla: 11.6	Cell type enhanced	Detected in single		classical monocyte: 1.0	Low lineage specificity	Detected in single			Group enriched	Detected in some	5	HMC-1: 5.1;SK-BR-3: 9.6	Low region specificity	Detected in many												Secreted to blood			510000					unprognostic (1.32e-1)	unprognostic (3.10e-1)	unprognostic (2.35e-1)	unprognostic (2.73e-3)	unprognostic (3.37e-1)	unprognostic (1.15e-4)	unprognostic (3.06e-2)	unprognostic (6.50e-2)	unprognostic (2.22e-2)	unprognostic (2.60e-1)	prognostic favorable (4.44e-4)	unprognostic (9.46e-2)	prognostic favorable (1.29e-9)	unprognostic (4.76e-3)	unprognostic (1.91e-1)	unprognostic (2.86e-2)	unprognostic (1.07e-1)	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0	0.8	0.7	2.1	3.3	0.2	1	1	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0	1.4	1.3	0.3	1.5	1.1	0	0	0	1	0.3	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0.1	0	0	0.7	0	0	0	0	0	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	9.6	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0.3	0	0	0	0.1	0.8	4.3	0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0	0.3	0	0.1	0.1	0	0.8	0	1.4	1.2	12.2	0	0.1	5	0	1.7	1.8	0.9	0	0	0.1	0.7	4.4	0	0	2.1	0	15.6	0	0.8	0	0.3	0.7	0	1	0	0	0	0	0.4	99.7	0	0	0.3	0.5	0.2	0.1	0.1	0	0.6	0.1	Proximal tubular cells
SLC3A1	ATR1, CSNU1, D2H, NBAT, RBAT	ENSG00000138079	Solute carrier family 3 member 1	Q07837	2	44275458-44321494	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Amino-acid transport, Transport		Cystinuria, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 66.0;kidney: 191.5;pancreas: 36.8	Cell type enriched	Detected in many	4	Proximal tubular cells: 256.0	Cancer enriched	Detected in many	7	renal cancer: 61.9	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	17	RPTEC TERT1: 49.9	Not detected	Not detected			Low region specificity	Detected in all			HPA038360, HPA071102	Enhanced		Approved	Nuclear bodies,Mitochondria						Mitochondria	Nuclear bodies	HPA038360: AB_2675975, HPA071102: AB_2732171	unprognostic (1.67e-2)	unprognostic (1.74e-1)	unprognostic (1.39e-1)	unprognostic (1.43e-2)	unprognostic (6.14e-2)	unprognostic (9.45e-2)	unprognostic (2.76e-2)	unprognostic (1.34e-1)	unprognostic (3.90e-1)	unprognostic (8.73e-2)	unprognostic (1.16e-1)	unprognostic (3.17e-1)	prognostic favorable (3.67e-7)	unprognostic (6.10e-2)	unprognostic (1.26e-1)	unprognostic (3.77e-1)	unprognostic (1.58e-4)	0.2	0.1	0.2	0.7	0.2	0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4	1.3	2	1.3	1.6	2.7	0.3	0	0.9	0	0.1	0.1	0.1	0.2	0	0	0	0	2.6	0	0	2.8	0	0	0.1	0	0.1	0.1	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0.1	0.2	0	0.1	0	0.1	0.1	0	0	0.3	0	0.9	0.2	0	0.1	0.2	49.9	0	0.1	0.1	0.1	0	0	0	0.1	0	0	0.1	0.2	0.1	0	0.2	0	0.2	0	0.1	0.1	1.3	1.3	1	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4	2.5	2.7	2	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1	3	1	1.5	0.2	0	12.5	0.3	63.7	0	0	40.1	9.8	0	53	18.3	10.9	0	32.7	0	12.6	0	0.2	1.4	0	2.8	0.1	20.6	0	0.6	0	3.3	1.1	0	0	2.8	3.8	1.6	3.4	7.2	0.4	256	11.9	0	0.1	0.7	0.3	0.1	0.1	0	8	0.5	Proximal tubular cells
RBP5	CRBPIII	ENSG00000139194	Retinol binding protein 5	P82980	12	7123684-7128942	Plasma proteins, Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3	Cell type enriched	Detected in many	7	Proximal tubular cells: 2221.9	Group enriched	Detected in all	8	liver cancer: 70.1;renal cancer: 126.4	Not detected	Not detected			Cell type enhanced	Detected in some		memory CD8 T-cell: 1.5;T-reg: 2.4	Group enriched	Detected in many	12	granulocytes: 1.3;T-cells: 2.4	Cell line enhanced	Detected in many		HEL: 7.0;Hep G2: 15.6;K-562: 32.0					Low region specificity	Detected in all			HPA038723	Enhanced		Approved	Golgi apparatus,Vesicles						Golgi apparatus	Vesicles	HPA038723: AB_2676175	unprognostic (5.70e-3)	unprognostic (7.34e-2)	unprognostic (2.72e-2)	unprognostic (1.53e-2)	unprognostic (1.87e-2)	unprognostic (1.39e-3)	unprognostic (2.49e-2)	prognostic favorable (8.37e-4)	unprognostic (1.04e-1)	unprognostic (2.65e-1)	unprognostic (1.13e-2)	unprognostic (1.13e-1)	unprognostic (1.04e-1)	unprognostic (1.83e-2)	unprognostic (3.33e-2)	unprognostic (4.22e-1)	prognostic favorable (3.68e-4)	1.5	2.6	0.3	18.2	0.3	0.7	1.3	0.6	0.3	2.8	1.7	0.1	2.3	1.4	5.3	13.3	2.3	1.5	3.6	2.3	0.3	0.3	99.9	74.2	3.6	54.3	0.2	0	3.5	1.3	0.2	1.6	0.1	0.1	2.6	1.6	0.7	5.9	3.3	0.4	0.7	4.4	1.8	0.2	44.3	1.2	1.2	0	6.2	2	0.7	10.1	2.3	1.4	0.1	0	1.3	0	0	2.4	0.1	1.8	3.2	0	1	0	0	0.7	1.2	0	0	0.2	1.7	2	1.1	0.5	0	0.2	2.3	0.1	0	0	2.8	0	7	5	15.6	0	0.4	2	0.3	0.1	0	0	3.2	0	1.1	32	1.5	0	0	0.1	0.4	0.4	0	0.1	0.4	0	0.1	0.1	2.7	0.1	0.3	2.8	1.1	0	0.9	0.6	1.1	1.1	1.3	1.3	3.7	0.5	0.6	0.2	0.2	0.9	1.5	0.2	1.3	0	0	0.4	0	0	0.1	0.1	1.5	0	0	0	0.1	0.2	0	0	0	2.4	0.1	0.3	0.3	0.6	0.3	0.3	0.3	0.2	0	0.1	0	0	1.1	1.4	0.4	1.3	1.2	0	2.5	1.4	0	76.8	0	0	298.4	0.2	3.2	9	0	0	0.4	0	0.9	0.4	0	302.4	0.1	4.8	0	10.4	6.4	5.4	2.3	0	0	0	0	1.7	0.3	0	0.4	2221.9	1.6	0	1	0.2	0.4	1.9	0	2.1	0	0.3	Proximal tubular cells
CLEC18B	MRCL2	ENSG00000140839	C-type lectin domain family 18 member B	Q6UXF7	16	74408270-74421953	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	kidney: 28.1	Cell type enriched	Detected in some	11	Proximal tubular cells: 18.2	Group enriched	Detected in some	12	glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 2.9;JURKAT: 4.1;K-562: 7.3;U-266/70: 2.7									HPA048976	Uncertain				Secreted to blood							HPA048976: AB_2680582	unprognostic (5.69e-2)	unprognostic (1.46e-1)	unprognostic (5.30e-3)	unprognostic (9.37e-2)	prognostic unfavorable (2.07e-4)	unprognostic (7.15e-2)	unprognostic (7.51e-2)	unprognostic (4.49e-3)	unprognostic (2.17e-1)	unprognostic (2.28e-1)	unprognostic (9.91e-2)	unprognostic (3.58e-2)	unprognostic (1.42e-2)	unprognostic (2.31e-2)	unprognostic (5.87e-2)	unprognostic (5.43e-2)	unprognostic (4.27e-2)	0.1	1.1	1.1	0.3	1.4	0.1	0.1	2.5	1.2	0.1	0.1			0.4	0.1	0.6	1.2	0.1	0.3	0	1	1	28.1	0.1	0	0.1	1		0.1	0.3	0.1	0.1	0.1		0.2	0.1		0.2	0	0.2	0	0.2	0.1	2	0.1	0.1	6.1			0.1		0.1	0	0.6	0	0	0	0.9	0.6	0	0	0	1.6	2.9	1.8	0	0.1	0.2	0.2	0	0	0	0	0.7	0.2	1.1	0.5	0.5	1	0.9	0	0.1	0.3	0.2	0.4	0.3	0.1	0.7	0	0.3	1.7	0.4	0.1	0.1	0.7	0	4.1	7.3	0	0.3	0	0	0	1.2	0.3	0.8	0.4	0	1.6	0	0.3	0.6	0.3	0	0	0	0.3	0.3	0	0	0.3	0.4	0.2	0.9	2.7	1.6	0.3	0.5	0.2	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0.9	0	0	0											0	0	0	0	0.1	0.4	0.1	0	0	0	0	0	0	1.7	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	1.2	0	0	1.1	0.3	0	0	0	0.3	0.6	0.4	0	0	18.2	1.1	0	0.1	0.3	0.2	0.1	0	0	0	0	Proximal tubular cells
SCRN2		ENSG00000141295	Secernin 2	Q96FV2	17	47837692-47841333	Enzymes, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Proximal tubular cells: 296.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA022934, HPA023434	Enhanced		Supported	Nucleoplasm,Golgi apparatus					350000	Nucleoplasm	Golgi apparatus	HPA022934: AB_1856638, HPA023434: AB_1856639	unprognostic (2.35e-2)	unprognostic (1.42e-2)	unprognostic (2.86e-1)	unprognostic (6.14e-2)	unprognostic (2.46e-2)	unprognostic (1.73e-1)	prognostic favorable (3.86e-4)	unprognostic (4.63e-2)	unprognostic (3.25e-2)	unprognostic (5.77e-2)	unprognostic (1.28e-3)	unprognostic (8.72e-2)	unprognostic (3.43e-2)	unprognostic (5.28e-3)	unprognostic (1.64e-1)	unprognostic (1.20e-1)	prognostic favorable (5.83e-4)	43.4	10.3	8.3	14.2	14.1	6.7	20.8	17.7	13.1	10.6	17.3	11.2	23.6	25.1	11.4	18.1	8.9	15.4	13.3	17.9	8.6	8.9	29.3	17.4	8.3	8.7	8.1	9.6	11.8	25.3	11.4	14.5	7.8	10.5	13.6	6.1	14.8	20.1	19.2	20	10.9	20.1	9.7	7.3	15	9.8	4	10.9	8.5	18.1	9	11	10.7	10	16.9	19.2	25.9	13.4	16.5	22.1	10.8	12	19.2	5.3	5.1	15.7	12.2	16.3	6.1	12.5	9.4	9.6	14.4	14.4	6.7	12.3	3.2	5	6.6	1.7	10.7	3.2	15.9	13.2	6.8	14.1	12.4	5.6	3.2	5.4	11.7	8.1	5.7	4.5	14	10.5	16.2	2.3	7.6	12.8	10.9	10.7	5.6	2.7	5.2	7.6	14.3	4	26.9	7.4	5.5	4.1	17.2	3.4	7.3	8	3.8	16.6	6.4	4.8	8.6	9.2	2.4	2.8	31.5	4.1	3.1	23.3	5.7	1.9	12.3	12.8	25.9	16.9	13.4	16.3	16.9	14	16.4	16.3	15.6	22.1	12.2	3.2	16.5	6.5	19.2	13.9	10.8	8.3	14.1	17.7	13.1	8.6	8.9	8.1	9.6	10.5	10.9	35.7	25.1	11.2	25.9	14	11.3	19.8	12.7	26.8	14.8	15.7	9.8	38.7	63	22.9	2.8	20.3	52	0	53.1	8.3	23.5	18.8	16.1	25.3	19.4	19.1	21.5	23.9	8.1	2.1	30.8	12.7	40.5	11.8	30.3	26.6	27.6	34.5	15.6	296.5	15.6	6.5	17	5.2	14.9	10	28.3	26.1	34.7	16.9	Proximal tubular cells
NAT8	ATase2, GLA, Hcml1, TSC501	ENSG00000144035	N-acetyltransferase 8 (putative)	Q9UHE5	2	73640832-73642393	Enzymes, Predicted membrane proteins		Acyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	kidney: 140.4	Cell type enriched	Detected in some	12	Proximal tubular cells: 1951.9	Cancer enriched	Detected in some	5	renal cancer: 242.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	15	Hep G2: 16.9					Low region specificity	Detected in all			HPA067855, HPA074519	Enhanced		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA067855: AB_2732774, HPA074519: AB_2686699	unprognostic (4.51e-2)	unprognostic (6.36e-2)	unprognostic (1.95e-1)	unprognostic (1.81e-1)	unprognostic (1.98e-1)	unprognostic (4.95e-3)	unprognostic (2.46e-1)	unprognostic (1.90e-2)	unprognostic (9.42e-2)	unprognostic (1.82e-1)	unprognostic (2.13e-2)	unprognostic (8.60e-2)	unprognostic (1.37e-3)	unprognostic (2.07e-2)	unprognostic (4.11e-3)	unprognostic (2.13e-2)	unprognostic (8.36e-5)	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0	0.2	0.2	0.2	0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	1.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0.1	0	0	0.9	0	0.1	0	0.1	0	0	0.1	0	0	0	0	1.1	0	0.1	0.4	0	0.1	0	0	0	0	0.2	0.1	0	0	16.9	0	0.1	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.3	0.1	0	0.1	0	0.1	0	0.2	0	0.3	0.2	0.1	0	0.6	0	0	0	0	0	0.4	0	0	0.1	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	1.9	0	0	0	0	0	0	0	34.9	0	0	159.2	0	0	0	1.3	0	0	0	0	0	0	40.4	0	0	0	22.7	1	0	0	0	0	0	0	0	0	2.9	0	1951.9	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
CLTRN	NX17, TMEM27	ENSG00000147003	Collectrin, amino acid transport regulator	Q9HBJ8	X	15627318-15665031	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	kidney: 204.4	Cell type enriched	Detected in some	15	Proximal tubular cells: 679.1	Cancer enriched	Detected in many	35	renal cancer: 106.2	Region enriched	Detected in single	9	pons and medulla: 5.0	Cell type enhanced	Detected in some		naive CD4 T-cell: 3.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5	Not detected	Not detected			Not detected	Not detected			HPA048543	Enhanced		Approved	Endoplasmic reticulum,Vesicles						Endoplasmic reticulum, Vesicles		HPA048543: AB_2680436	unprognostic (1.27e-1)	unprognostic (4.77e-2)	unprognostic (2.45e-2)	unprognostic (2.66e-2)	unprognostic (5.20e-2)	unprognostic (5.23e-2)	unprognostic (1.25e-1)	unprognostic (8.50e-2)	unprognostic (1.90e-2)	prognostic favorable (5.65e-4)	unprognostic (1.05e-2)	unprognostic (3.03e-1)	prognostic favorable (6.78e-9)	unprognostic (1.77e-1)	unprognostic (2.60e-2)	unprognostic (2.58e-1)	unprognostic (1.33e-2)	0.1	0.2	0.3	0.1	0.4	0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4	0.2	0.7	5	0.3	0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0	0.5	0	3	0.4	3	2.1	1.5	0.6	0.8	1.2	1	0.1	0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0	0.4	1.4	0.3	0	1	1.6	0	0	0.2	2.4	0.4	6.1	0.7	0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2	6.5	1	0.3	0.1	0.2	0.5	0.4	0	0.5	0.3	0.4	0.9	0.1	0.1	0	0.5	0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3	0.9	0	0	0	0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5	0.1	0	2.6	0	0	0	0	0	0	4	3.4	26.2	0	1.9	46.4	19.8	0	0	0	0	0.5	0.3	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	679.1	0	0	0	0	0	0	2.5	0	0	0	Proximal tubular cells
SLC5A12	MGC52019, SMCT2	ENSG00000148942	Solute carrier family 5 member 12	Q1EHB4	11	26667019-26723427	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	intestine: 60.8;kidney: 90.3	Cell type enriched	Detected in some	18	Proximal tubular cells: 145.9	Cancer enriched	Detected in single	26	renal cancer: 9.0	Region enriched	Detected in single	7	basal ganglia: 1.2	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8	Not detected	Not detected			Not detected	Not detected			HPA060904	Enhanced		Supported	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA060904: AB_2684385	unprognostic (3.69e-3)	unprognostic (6.92e-2)	unprognostic (1.79e-1)	unprognostic (2.86e-1)	unprognostic (2.01e-2)	unprognostic (9.35e-3)	unprognostic (4.21e-3)	unprognostic (4.49e-2)	unprognostic (2.36e-3)	unprognostic (1.71e-1)	unprognostic (2.03e-2)	unprognostic (3.43e-1)	unprognostic (2.91e-3)	unprognostic (1.34e-1)	unprognostic (8.53e-2)	unprognostic (1.42e-2)	unprognostic (9.40e-3)	0	0	0.1	0	1.2	0.2	0	0	0.1	0	11.3	0	0.2	1.7	0	18.5	0	0	0	3.4	0.1	0.1	90.3	0.4	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	60.8	0	0.1	0.1	0	0.1	0	0	0	0	0	0.1	0	1.5	0.8	1	0.7	0.9	0.7	0.1	0.4	0.1	0.2	0.6	0.1	0	0.5	0.1	0	0	0	0.6	0.2	0.6	0.8	0.2	0.1	0.2	0.2	0.1	0.1	0	0	0.1	0.7	0.1	0.2	0	0.2	0.1	0	0.1	0	0.2	0.1	0.3	0.4	5.2	0.1	0.3	0.2	0.5	3.8	0.7	0.1	0.1	0	0.6	0.1	1.1	2	0.3	1.7	0.2	0	7.8	2.8	0.5	0.6	0.4	0.2	0.4	0.2	2.3	0.7	0.2	0.2	0	0	1	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	3.8	0	0	0	3.5	0	0.1	8.3	0	0.7	0	1.7	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0.8	0	0.3	0	145.9	0.2	0	0	0	0.4	0	0.1	0	0.4	0	Proximal tubular cells
SLC22A8	OAT3	ENSG00000149452	Solute carrier family 22 member 8	Q8TCC7	11	62989154-63015839	FDA approved drug targets, Predicted membrane proteins, Transporters	Detoxification, Ion transport, Transport		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	341	brain: 33.7;kidney: 127.3;retina: 93.5	Cell type enriched	Detected in some	30	Proximal tubular cells: 197.4	Cancer enhanced	Detected in single		renal cancer: 0.6	Region enriched	Detected in some	25	pons and medulla: 33.7	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	13	EFO-21: 1.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044174	Enhanced											HPA044174: AB_10963058							unprognostic (5.35e-4)					unprognostic (4.66e-1)	unprognostic (6.88e-3)	unprognostic (1.72e-1)	unprognostic (2.20e-1)			0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1	0.1	0.1	3.8	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	127.3	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.2	0.1	33.7	0.1	0.1	93.5	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0	0	0.1	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.4	1	0.7	0.1	0.1	1.3	33.7	0	0	0	0	0	0	3.7	0.8	0	0	0	5.2	0	0	6.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	197.4	0.9	0	0	0	0	0	0	0	0	0	Proximal tubular cells
CLEC18A	MRCL	ENSG00000157322	C-type lectin domain family 18 member A	A5D8T8	16	69950705-69964452	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	kidney: 19.6	Cell type enriched	Detected in some	18	Proximal tubular cells: 57.3	Cancer enriched	Detected in single	7	renal cancer: 1.5					Cell type enhanced	Detected in single		neutrophil: 1.6	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 2.8;BEWO: 3.6									HPA048976	Uncertain				Secreted to blood							HPA048976: AB_2680582	unprognostic (1.68e-1)	unprognostic (3.06e-2)	unprognostic (1.19e-2)	unprognostic (1.48e-1)	unprognostic (3.14e-2)	unprognostic (4.62e-2)	unprognostic (1.36e-1)	unprognostic (4.14e-2)	unprognostic (1.04e-1)	unprognostic (4.40e-2)	unprognostic (6.77e-4)	unprognostic (6.73e-2)	unprognostic (4.58e-2)	unprognostic (2.06e-1)	unprognostic (9.03e-4)	unprognostic (1.52e-1)	unprognostic (2.53e-2)	0.1	1.3	0.3	0	0.8	0.3	0.1	0.1	0.1	0.1	0.2			0	0	0	0.1	0.3	0.1	0.1	0.3	0.5	19.6	0.1	0.1	0.1	0.3		0.1	0.3	0	0.1	0		0.1	0.1		0.7	0.1	0	0.1	0.5	0	1	0.7	0.5	3.4			0.1		0.1	0.4	0	0.9	0.3	1.6	0	0.5	0.1	0	0.3	0.3	2.8	0.2	0	0.8	3.6	0	0	0.6	0.2	0.6	0.1	0.5	0.3	0	0.5	0	0	0.4	0.3	0.6	0.9	0	0	1.5	0	0.7	1.8	0	1.4	1.4	0	0.9	0	0	0	0.5	0	0	0	0.1	0.7	0.1	0	0.2	0.4	0	0	1	1.6	0.1	0.8	0	0.1	0.5	0.7	1.6	0	0.7	1.9	0.2	0	0.7	0.8	0	0.6	0	1.1	0	0	0	0	0	0.1	0	0	0	0.3	0.9	0	0	1.6	0.5	0	0	0	0											0	1.4	0.5	0	0.1	1.2	0.4	0	0	0	0	2	0.1	1.7	0.2	0.2	0.2	1.1	0	0.2	0	0.1	0.3	0	0	0.3	3.2	0	1.3	0	0.6	0.3	0.1	0	0	0.9	1.5	0.5	0	0	57.3	1.1	0	0.2	0.5	0.1	0	0.2	0	1.6	0.1	Proximal tubular cells
CLEC18C	MGC34761, MRCL3	ENSG00000157335	C-type lectin domain family 18 member C	Q8NCF0	16	70173322-70187361	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	13	kidney: 16.5;testis: 4.6	Cell type enriched	Detected in single	48	Proximal tubular cells: 18.8	Cancer enriched	Detected in single	9	renal cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.0;RT4: 1.3;TIME: 3.0									HPA048976	Uncertain				Secreted to blood							HPA048976: AB_2680582		unprognostic (3.90e-1)		unprognostic (3.03e-1)	unprognostic (1.20e-4)					unprognostic (5.55e-2)	unprognostic (5.72e-3)	unprognostic (2.92e-1)	unprognostic (7.64e-2)	unprognostic (3.79e-2)	unprognostic (3.61e-3)		unprognostic (6.98e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0	16.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0.8	0	0.2	0	0.8	0	0	0	0	0.3	0.6	0	0	0.2	1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.4	0	0.3	0.3	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.5	0.6	0	0	0.6	0.3	1.3	0.5	0.2	0	0	0	0.3	0	0.6	3	0	0.1	0	0.2	0.4	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0.2	0.1	0.1	0.5	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.8	0	0	0	0.1	0	0	0	0	0	0	Proximal tubular cells
PDZK1IP1	DD96, MAP17, SPAP	ENSG00000162366	PDZK1 interacting protein 1	Q13113	1	47183593-47191044	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	kidney: 281.3	Cell type enriched	Detected in many	4	Proximal tubular cells: 4006.8	Cancer enhanced	Detected in all		renal cancer: 340.7	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	6	EFO-21: 31.5;RPTEC TERT1: 104.5	Not detected	Not detected							HPA014907	Enhanced		Approved	Nuclear speckles,Cytosol						Cytosol	Nuclear speckles	HPA014907: AB_1855166	unprognostic (2.97e-1)	unprognostic (3.33e-2)	unprognostic (1.03e-1)	unprognostic (9.16e-2)	prognostic unfavorable (6.92e-4)	unprognostic (8.14e-3)	unprognostic (2.32e-1)	unprognostic (1.46e-1)	unprognostic (2.65e-1)	unprognostic (2.31e-1)	prognostic unfavorable (3.45e-4)	unprognostic (2.64e-2)	unprognostic (7.90e-3)	unprognostic (1.22e-1)	unprognostic (2.07e-1)	unprognostic (1.75e-3)	unprognostic (1.89e-1)	2.7	1.2	0.6	2.4	0.6	3.9	4.1	0.6	0.6	9.2	9.1	0.6	0.6	2.2	1.3	4.8	30.4	2.9	23.9	0.7	0.5	0	281.3	1.6	7.2	0.5	0.6	0.5	2.3	16.8	0	0.6	3.2	0.6	2.1	3.4	0.8	33.9	12.4	0.7	19.9	9.5	0.5	0.5	0.7	9	1.4	0.6	1.1	1	18.3	18.5	4.1	8.3	0.1	0.5	2.1	1.1	0.2	0.3	42.4	11	0.6	0	0	0	0	0	0	0	0	0	0.6	8.6	0	31.5	0	0	0.1	0	0.1	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0.5	104.5	0	0	0	0.1	0.9	0	0	0.2	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	1.1	0.1	0.2	0.3	0	0	0	0	0.5	0.1	0	0	2.1	0.2	0	0.5	0.3	42.4	0.6	0.6	0.6	0.6	0.5	0	0.6	0.5	0.6	0.6	71.5	39.6	6.7	11.1	12.6	0	0	359.2	6.7	34.2	221.6	0	0	351.5	818	0	1.6	60.9	140.2	656.9	0	0.9	37.3	10.4	1	0.2	0	38.1	2.5	0.3	0	3.1	1.5	8.5	21.6	123.8	0.5	959.8	81.8	0	4006.8	0	0	2.3	0	0.1	47.2	0.7	1.5	119.5	16.8	Proximal tubular cells
FAM151A	C1orf179, MGC27169	ENSG00000162391	Family with sequence similarity 151 member A	Q8WW52	1	54609182-54623556	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	intestine: 45.8;kidney: 59.3	Cell type enriched	Detected in some	7	Proximal tubular cells: 116.1	Group enriched	Detected in many	5	liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2	Not detected	Not detected			Cell type enriched	Detected in single	6	eosinophil: 2.4	Lineage enriched	Detected in single	6	granulocytes: 2.4	Cell line enriched	Detected in single	45	CACO-2: 41.7	Not detected	Not detected			Not detected	Not detected			HPA016840	Approved											HPA016840: AB_2669461	unprognostic (1.89e-1)	unprognostic (6.90e-3)	unprognostic (3.73e-2)	unprognostic (1.97e-6)	unprognostic (1.71e-2)	unprognostic (4.84e-3)	unprognostic (1.02e-1)	unprognostic (3.46e-2)	unprognostic (2.87e-1)	unprognostic (1.05e-2)	unprognostic (4.91e-3)	unprognostic (9.99e-2)	prognostic favorable (4.09e-5)	unprognostic (5.85e-2)	unprognostic (8.97e-2)	unprognostic (1.13e-1)	unprognostic (1.40e-3)	0.1	0	0.1	0.6	0.1	0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.6	0.1	0.1	0.2	0	0.1	0.8	0.1	0	59.3	5.6	0.1	1.6	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0	45.8	0.1	0.1	0.5	0	0.3	0.1	0.3	0.1	0.1	0.9	0.1	0.1	0	0.4	2.4	0	0	0	0	0.3	0	0	0	0	0	0.1	0.1	0	0	0	41.7	0.5	0	0.2	0	0.1	0.6	0	0	0	0.2	0	0.9	0.2	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.8	0	0	0.4	0	0	0.8	0.2	0.2	0	0	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0.8	0	0	0	2.4	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0.5	0.1	0	0	0.3	0	0	0	7	0	0	11.6	0	4.1	0	12	0	0	0	0	0	0	16.2	0	0	0	0	0.3	9.3	0	0	0	0	0	0.3	0	5.8	0	116.1	0	0	0	0	0	0	0	0	1.4	0	Proximal tubular cells
FCAMR	CD351, FCA/MR, FKSG87	ENSG00000162897	Fc fragment of IgA and IgM receptor	Q8WWV6	1	206957965-206970625	CD markers, Predicted membrane proteins	Adaptive immunity, Immunity	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0	Cell type enriched	Detected in some	8	Proximal tubular cells: 26.5	Cancer enhanced	Detected in some		renal cancer: 5.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.9;HMC-1: 1.0									HPA056505	Enhanced								3600000			HPA056505: AB_2732604	unprognostic (2.94e-1)	unprognostic (1.06e-1)	unprognostic (8.53e-2)	unprognostic (2.92e-1)	unprognostic (7.44e-2)	unprognostic (4.55e-3)	unprognostic (2.69e-3)	unprognostic (1.08e-4)	unprognostic (3.61e-2)	unprognostic (1.25e-1)	unprognostic (1.82e-1)	unprognostic (1.23e-1)	unprognostic (1.11e-1)	unprognostic (1.29e-1)	unprognostic (3.88e-2)	unprognostic (2.08e-1)	unprognostic (1.26e-1)	0.1	0.1	0.1	23	0.1	0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	23.9	7.6	0.1	8.3	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	2.4	0.1	0.1	0.1	1	0.1	0.5	0.6	0.1	0.2	0.1	0.2	0.2	0.1	9.1	0.1	0.1	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.3	0	1.9	0.3	0.1	0.1	0	0	0.1	0	0	0.4	0	0	0.2	0	0	0	0	1	0	0.2	0	0.2	0	0	0.1	0.1	0	0	0	0.3	0.4	0.1	0.3	0	0.2	0.5	0	0.2	0	0	0	0	0.8	0	0	0	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	3.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	26.5	0	0	0	0	0	0	0	0	0.6	0	Proximal tubular cells
TMEM174	FLJ31268, MGC13034	ENSG00000164325	Transmembrane protein 174	Q8WUU8	5	73173195-73175143	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	282	kidney: 61.5	Cell type enriched	Detected in some	11	Proximal tubular cells: 143.8	Cancer enriched	Detected in single	126	renal cancer: 6.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 2.7;RPTEC TERT1: 1.5	Low region specificity	Detected in single			Not detected	Not detected			HPA037975	Enhanced											HPA037975: AB_10672732					unprognostic (8.11e-2)								prognostic favorable (3.30e-6)					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	2.7	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.2	0	0	13.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	143.8	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SLC16A9	C10orf36, FLJ43803, MCT9	ENSG00000165449	Solute carrier family 16 member 9	Q7RTY1	10	59650761-59736002	Predicted membrane proteins, Transporters	Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	adrenal gland: 58.0;kidney: 70.9	Cell type enriched	Detected in many	7	Proximal tubular cells: 218.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA049286	Approved		Approved	Nucleoplasm,Cell Junctions						Nucleoplasm	Cell Junctions	HPA049286: AB_2680699	unprognostic (3.39e-2)	unprognostic (6.91e-2)	unprognostic (1.30e-1)	unprognostic (1.27e-1)	unprognostic (1.60e-3)	unprognostic (1.76e-2)	unprognostic (5.96e-2)	unprognostic (3.50e-3)	unprognostic (5.01e-2)	unprognostic (2.11e-3)	unprognostic (5.99e-2)	unprognostic (4.60e-2)	prognostic favorable (2.56e-6)	unprognostic (7.57e-3)	unprognostic (1.27e-2)	unprognostic (3.72e-1)	unprognostic (1.94e-1)	0.7	58	5.7	2	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3	6	14.3	2.4	3.4	6.5	0	11.2	4.4	3.1	0.9	4.8	0	0	0	0	0	0.3	0.3	0	0.2	4.2	5.6	0	0	0	0	0	0.2	0.3	0	0.2	0	0.6	0	0	0.7	8.7	0	0	0	1.4	0.1	0.2	0	0.1	1.8	0	0.4	0.1	0	2.3	0.1	0.3	4.4	6.1	0.1	0.4	3.3	2.3	0	16.4	1.6	7.5	2.7	0.2	5.7	0	0.2	2.8	7.9	0.1	0.3	0	8.8	2.8	3.6	2.6	0.4	0.9	0.1	8.3	0	0	0	0	14.8	1.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	5.7	4.6	9.9	4.3	10	2.6	6.7	5.5	8.2	6.5	0	0	0	1.1	0.1	4.7	2.8	0	4	9.1	7	0	0	21.6	0.7	0.1	0	17.7	0	0	0.8	1.2	12.7	0	0	0.1	3.2	19.3	0	10.5	0.4	12.7	0	3.3	1	15.5	11.2	0.2	30.3	11.3	218.2	0.8	0	2.8	0.3	0.1	0.1	0	0	12.8	5.7	Proximal tubular cells
SLC22A13	OAT10, OCTL1, OCTL3, ORCTL3	ENSG00000172940	Solute carrier family 22 member 13	Q9Y226	3	38265812-38278315	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	kidney: 16.4	Cell type enriched	Detected in single	23	Proximal tubular cells: 6.5	Cancer enriched	Detected in single	7	renal cancer: 0.7	Not detected	Not detected			Cell type enriched	Detected in single	5	T-reg: 2.3	Lineage enriched	Detected in single	5	T-cells: 2.3	Cell line enhanced	Detected in some		HeLa: 2.2					Low region specificity	Detected in all			HPA035603, HPA035962	Enhanced											HPA035603: AB_10672869, HPA035962: AB_2674890	unprognostic (2.73e-2)	unprognostic (6.70e-2)	unprognostic (2.80e-1)	unprognostic (5.68e-2)	unprognostic (7.13e-3)	unprognostic (3.50e-3)	unprognostic (6.83e-2)	unprognostic (1.49e-1)	unprognostic (3.48e-1)	unprognostic (2.09e-1)	unprognostic (3.04e-1)	unprognostic (1.92e-1)	unprognostic (8.65e-5)	unprognostic (3.39e-1)	unprognostic (1.96e-2)	unprognostic (5.24e-2)	unprognostic (2.74e-1)	0	0	0	0	0	0.1	0	0.6	0.1	0	0	0	0	0	0	0	0.4	0	0.1	0	0	0	16.4	0.1	0	0	0	0	0	0.1	0	0.7	0	0	0	0.1	0	1.3	0	0.2	0	0.3	0	0	0	0.1	0.5	0	0	0	0	0	0.2	0.2	0.4	0	0.1	0.3	0	2.3	0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.3	0	0.2	0.3	0	0.5	0.9	0.2	0.1	0.6	0.8	0.5	0.7	0.1	0.4	0.1	0	2.2	0	0.1	0	0.8	0	0.5	0.1	1.5	0.8	0	0.9	0	0.1	1.1	0.1	0.1	0	0	0.2	0.5	0	0	0.2	0	1.2	0.1	0.1	0	0.5	0	0.4	0.1	0.1	0	0.3	0.7	1.2	0.3	0.3	0.4	0.4	0.9	0	0	0	0.2	0	0	0.3	0.3	0.4	0.1	0.3	0	0.3	0.3	0	0.1	0	0	0	2.3	0	0	0	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
UGT2A1		ENSG00000173610	UDP glucuronosyltransferase family 2 member A1 complex locus	Q9Y4X1	4	69588417-69653249	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Olfaction, Sensory transduction	Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	kidney: 10.6;liver: 14.5;pituitary gland: 21.2	Cell type enriched	Detected in some	6	Proximal tubular cells: 32.3	Cancer enhanced	Detected in some		liver cancer: 0.7	Region enriched	Detected in single	17	pons and medulla: 1.7	Cell type enhanced	Detected in some		neutrophil: 2.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6									HPA017261, HPA045108	Uncertain											HPA017261: AB_10963582, HPA045108: AB_2679218							unprognostic (3.93e-3)	unprognostic (5.62e-1)					unprognostic (1.28e-4)	unprognostic (1.74e-1)	unprognostic (2.76e-2)			0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	10.6	14.5	2.4	0	0	0	0	0	0	21.2	0	1.7	0	0	1.5	0	0.2	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0.5	2	0.5	0.9	0.4	0	0	0	0.1	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0	0	0	0.9	0	0	0	1.9	0	0	0.2	0	0	0	0.1	0.4	0.3	0	0	0	0	0	0	0	0	0.3	0.1	0	0.9	0	0	0	0.1	0	0.1	0	3.6	0	0	0	0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2	0.9	0.2	0.5	0.1	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	2.5	0	0	3.5	0	0	5	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32.3	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
PDZK1	NHERF3, PDZD1	ENSG00000174827	PDZ domain containing 1	Q5T2W1	1	145670852-145708148	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 49.2;kidney: 124.3	Cell type enriched	Detected in some	6	Proximal tubular cells: 758.4	Group enriched	Detected in many	12	breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3	Region enriched	Detected in single	17	cerebellum: 10.0	Cell type enriched	Detected in many	4	NK-cell: 7.6	Lineage enriched	Detected in many	4	NK-cells: 7.6	Group enriched	Detected in some	4	RPTEC TERT1: 43.1;T-47d: 112.0	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA005755, HPA006155, CAB008971	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol						Nucleoplasm, Vesicles	Cytosol	CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163	unprognostic (4.56e-3)	unprognostic (3.07e-1)	unprognostic (8.79e-2)	unprognostic (4.41e-2)	unprognostic (9.15e-2)	unprognostic (2.09e-1)	unprognostic (2.18e-1)	unprognostic (3.42e-1)	unprognostic (2.08e-1)	unprognostic (3.27e-1)	unprognostic (2.34e-2)	unprognostic (9.87e-3)	prognostic favorable (2.54e-7)	unprognostic (9.90e-2)	unprognostic (3.02e-1)	unprognostic (1.00e-3)	unprognostic (8.87e-2)	0.1	0.6	0.2	0.2	0.3	0	5.8	10	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1	1.1	0.5	0.2	7.6	1.8	0.5	1.3	0.2	0.1	0.1	0	0	0.5	0.2	0	0	0.1	18.9	0.1	0.1	0.2	1.1	0	0.6	0	0.1	0.1	1.8	0.3	0.1	0.4	7.8	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0.3	0.1	1.1	0.1	0.2	0.2	0.2	0.5	0	1.3	0.2	43.1	0	0.1	1.2	0.3	0.3	0	1.2	112	0.1	0.1	0.2	0.2	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0	0.5	0.2	0.1	1.5	0.2	0.6	1	0.4	1.8	0.2	1	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10	0.2	0.2	0.2	0.3	0.2	0.5	0.1	0	0	0.9	0	0.1	0.4	0.4	61.1	0	0	54.1	0	0	117.7	1.7	8.9	0	18	0	1.6	0.1	0.2	0.1	0	45.6	0.2	0	6.3	1.8	1.2	5.2	0	0	0	0	0.5	0	1.8	2.9	0	758.4	0.3	0	0.3	0.2	0.2	0	0.1	0	1	0	Proximal tubular cells
MSRA		ENSG00000175806	Methionine sulfoxide reductase A	Q9UJ68	8	10054268-10428891	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 78.4	Cell type enriched	Detected in many	6	Proximal tubular cells: 597.4	Low cancer specificity	Detected in all			Region enriched	Detected in all	6	cerebellum: 78.4	Cell type enhanced	Detected in many		eosinophil: 9.0	Group enriched	Detected in many	4	dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2	Cell line enhanced	Detected in many		HMC-1: 15.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA023804, HPA075766	Approved		Supported	Nucleoplasm,Plasma membrane,Actin filaments,Cytosol	Intracellular and membrane	No	No		25000	Nucleoplasm, Plasma membrane, Cytosol	Actin filaments	HPA023804: AB_1853826, HPA075766: 	unprognostic (1.55e-1)	unprognostic (4.30e-3)	unprognostic (1.45e-3)	unprognostic (1.00e-2)	unprognostic (4.21e-2)	unprognostic (1.62e-2)	unprognostic (1.49e-2)	unprognostic (6.40e-2)	unprognostic (9.69e-2)	unprognostic (1.08e-1)	unprognostic (1.80e-1)	unprognostic (4.58e-2)	unprognostic (1.07e-3)	unprognostic (6.43e-3)	unprognostic (4.02e-1)	unprognostic (6.36e-3)	unprognostic (3.07e-1)	7	8.1	8	5.2	7.5	36.1	5.9	78.4	13.7	3.6	5.9	4.3	2.2	5.9	4.8	3.7	5.5	4.2	4.4	8.5	8.9	5.5	32.4	22.9	5.7	6.8	6.8	9.5	4.2	10.2	2.9	3.4	4.6	8.1	3.4	4	3.9	6	5	4.7	3.8	12.7	4.9	6.7	7.2	4.9	8.5	5.5	3.5	4.4	2.6	3.8	3.9	2.7	1.1	2.3	9	3.2	1.1	0.8	0.3	0.1	1.1	1.8	5.4	1.6	1.8	0.6	3.3	0.7	0.5	2.2	0.7	2.7	0	0.8	3	7.2	2.9	0.5	0.2	1.7	0.4	0	0.5	1.7	2.5	5.3	1	15.2	0.5	3.9	0.4	0	1.8	0.9	0.3	0.5	0.3	5.9	0.2	0	0.3	0.8	3.9	1	1.8	1.7	2.3	1.3	1.3	3.1	2	5.4	0.2	0.7	0.6	2.8	3.3	3.2	2.2	2.6	0.5	1.6	0.2	0.1	0.9	5.9	1	4.1	0.8	3.2	9	0.7	2.2	0.6	1.1	0.8	0.5	2.3	0.4	0.6	0.5	3.8	1.1	1.6	0.3	0.5	0.3	8	7.5	78.4	13.7	8.9	5.5	6.8	9.5	8.1	5.5	0	9	10	24.1	14.5	10.7	18.1	17.8	5.3	4.5	24.4	29.5	5.8	77.9	27	64.1	26.4	29	0	41.4	4.5	11.3	16.9	81.6	82.9	42.3	15.9	9.2	16.5	31	107.2	8.6	33.1	28.7	14.4	19.7	13.4	40.7	28.8	9.2	597.4	5.8	12.9	17.6	27.7	18.8	12.3	7	15.3	17.4	28.6	Proximal tubular cells
SLC47A2	FLJ31196, MATE2, MATE2-K	ENSG00000180638	Solute carrier family 47 member 2	Q86VL8	17	19678288-19718979	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	kidney: 55.5	Cell type enriched	Detected in some	13	Proximal tubular cells: 69.0	Cancer enhanced	Detected in some		renal cancer: 4.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 1.9;HeLa: 1.5;hTCEpi: 6.7					Not detected	Not detected																unprognostic (4.52e-3)	unprognostic (8.28e-3)	unprognostic (1.54e-1)	unprognostic (4.99e-2)	prognostic unfavorable (8.95e-4)	unprognostic (5.22e-2)	unprognostic (2.72e-1)	unprognostic (1.99e-2)	unprognostic (3.29e-2)	unprognostic (1.51e-1)	unprognostic (1.36e-3)	unprognostic (7.77e-2)	unprognostic (1.04e-3)	unprognostic (4.33e-2)	unprognostic (1.61e-1)	unprognostic (6.44e-2)	unprognostic (5.71e-2)	0.2	0.3	3	0.1	4.4	0.1	0.3	0.2	0.4	0.1	0.2	10.3	0.6	0.2	0.2	6.5	0.2	8.6	0.1	0.3	6.2	5.5	55.5	0.1	0.1	0.1	1.1	0.1	0.6	0.1	0.1	0	0.1	12.8	0.1	0.1	0.7	0.1	0.3	0.7	1.8	0.4	0.2	2	0.1	0.1	0.2	2.8	0	0.3	0.5	0.1	0.2	0	0	0	0	0	0.3	0.6	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0.4	0.6	0	1.2	0	0.2	1.9	0	0.1	0	0	0	0	1.5	1	0	0	0	0	6.7	0	0.3	0.1	0	0	0	0	0	0	0	0	0.5	1.2	0.8	0	0.3	0	0.1	0.3	0.5	0.2	0.4	0	0	1	0	0	0	0	0	0	0.1	0	0	0	0.8	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	3	4.4	0.2	0.4	6.2	5.5	1.1	0.1	12.8	2.8	0	0	0	0.2	0.2	0	0.6	0	0	0	5.2	0	0.1	5	0	0.3	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	2.1	0.1	0	0	69	0.2	0	0.3	0.5	0.2	0.3	0	0	0	0.1	Proximal tubular cells
TMEM132E	DFNB99	ENSG00000181291	Transmembrane protein 132E	Q6IEE7	17	34579487-34639318	Disease related genes, Predicted membrane proteins			Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 20.0;kidney: 8.8	Cell type enriched	Detected in some	7	Proximal tubular cells: 9.0	Group enriched	Detected in some	8	glioma: 7.6;renal cancer: 1.8	Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.6	Group enriched	Detected in many	20	NK-cells: 1.4;T-cells: 2.6	Cell line enriched	Detected in some	9	RPMI-8226: 31.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA070608	Approved		Approved	Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol					140000	Nucleoplasm, Golgi apparatus	Nuclear bodies, Cytosol	HPA070608: AB_2686286	unprognostic (1.92e-1)	unprognostic (1.68e-1)	unprognostic (3.29e-5)	unprognostic (3.37e-1)	unprognostic (1.37e-1)	unprognostic (8.61e-2)	unprognostic (1.06e-3)	unprognostic (1.72e-1)	unprognostic (1.80e-1)	unprognostic (1.56e-2)	unprognostic (2.16e-3)	unprognostic (1.25e-1)	prognostic unfavorable (1.55e-4)	unprognostic (1.67e-2)	unprognostic (1.51e-2)	unprognostic (2.65e-1)	unprognostic (8.71e-2)	0.4	0.5	4.9	0.4	4.1	0.2	0.3	17.3	8.7	1.2	0.4	1.7	0.3	4.9	0.6	0.5	0.4	0.4	0.8	0.5	2.9	5.1	8.8	1.3	0.4	0.7	4.5	2.8	0.5	0.2	0.3	0	0.9	5.3	0.4	0.5	0	0.8	0.8	0.3	0.8	2.8	0.6	20	0.7	0.6	2.4	2.2	0	0.4	0	0.6	0.7	0.1	0	0	0	0	1.4	2.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0.8	3.4	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.6	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	1.2	0	1.2	0	0.4	0.5	0	0	2.6	1.8	0	1.4	0	0	0	0.4	4.9	4.1	17.3	6.9	2.9	5.1	4.5	2.8	5.3	2.2	0	0	0	0	0.2	0	1.2	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0.6	1	1.4	0	0	0	0	0	0	0	0	0	9	0	0	0.4	0.7	1.3	0	0	0	0	0	Proximal tubular cells
TMEM252	C9orf71, MGC34760	ENSG00000181778	Transmembrane protein 252	Q8N6L7	9	68536580-68540867	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	intestine: 16.0;kidney: 64.2	Cell type enriched	Detected in some	9	Proximal tubular cells: 15.1	Cancer enriched	Detected in many	17	renal cancer: 35.7	Not detected	Not detected			Cell type enriched	Detected in single	8	neutrophil: 7.6	Lineage enriched	Detected in single	37	granulocytes: 7.6	Group enriched	Detected in some	6	EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.5;SK-BR-3: 3.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA079457	Enhanced											HPA079457: 	unprognostic (2.64e-1)		unprognostic (3.28e-3)	unprognostic (3.72e-1)	unprognostic (1.51e-1)	unprognostic (2.53e-2)	unprognostic (4.00e-2)	unprognostic (7.79e-3)		unprognostic (6.47e-2)	unprognostic (1.64e-2)	unprognostic (6.42e-2)	prognostic favorable (1.75e-7)	unprognostic (7.63e-2)	unprognostic (6.15e-2)	unprognostic (7.66e-2)	unprognostic (2.50e-1)	0.5	2	0.4	0.6	0.4	0	0.4	0.9	0.4	0.6	5.6	0.4	0.4	1	4.3	0.8	4.3	2.7	0.7	3	0.4	0	64.2	0.9	0.4	0.4	0.4	0.4	0.6	0.4	0	0.4	2.6	0.4	1.8	0	0.4	0.4	0.4	0.7	0.2	16	0.9	0.4	0.4	1.7	0.6	0.4	0.4	0.4	0.4	0.5	6	0.6	0	0.1	7.6	0.2	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0	0	3.4	0	1.9	0	6.5	0	0	0	0	3.7	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0.1	0.9	0	0.1	0	0	0	0	0.1	0	0	0	7.6	0	0.2	0	0	0	0.4	0.4	0.9	0.4	0.4	0	0.4	0.4	0.4	0.4	0	0	0	0	0	0	0.6	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
C9orf66	FLJ31158	ENSG00000183784	Chromosome 9 open reading frame 66	Q5T8R8	9	212824-215741	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	blood: 20.9;kidney: 17.8	Cell type enriched	Detected in many	4	Proximal tubular cells: 60.2	Cancer enhanced	Detected in some		renal cancer: 2.7	Not detected	Not detected			Cell type enhanced	Detected in many		neutrophil: 20.9	Group enriched	Detected in many	4	granulocytes: 20.9;monocytes: 6.0	Cell line enhanced	Detected in some		BEWO: 3.6;MCF7: 3.7;RT4: 3.6;THP-1: 7.8									HPA035652	Uncertain											HPA035652: AB_10601151	unprognostic (1.24e-1)	unprognostic (7.20e-2)	unprognostic (7.64e-2)	unprognostic (1.89e-1)	unprognostic (3.32e-1)	unprognostic (1.37e-1)	unprognostic (2.55e-1)	unprognostic (2.94e-2)	unprognostic (9.48e-2)	unprognostic (6.65e-3)	unprognostic (9.92e-2)	unprognostic (5.66e-2)	prognostic favorable (1.32e-5)	unprognostic (2.04e-2)	unprognostic (1.63e-1)	unprognostic (2.73e-2)	unprognostic (3.10e-3)	0.5	3.1	0.3	0.3	0.9	1.7	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0	0.3	0.3	0.5	0.1	0.3	0.3	0.3	0.1	17.8	0.5	0.3	0.3	0.3	0.3	0.5	1.3	1.9	0.3	0.3	0.3	0.7	0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	1.4	0.2	0.7	0.8	0.3	1.3	0.3	0.3	0.4	0.3	2	3	20.9	6	1.6	0.6	0.6	0.1	0.4	0.3	0.4	0.1	0.1	3.6	0.1	0	0.2	0.1	0.7	2.1	0.4	1	0.3	0.4	0.6	0.1	0	0	0.3	1.1	0.3	0.5	0.3	0.1	0.9	1.2	0.2	0.1	0.1	0	0.1	0	0.2	1.9	0.8	0	3.7	0.2	2.4	0.4	0.1	0.8	0.4	0.3	2.1	0.1	3.6	0.6	0.4	0	0.2	0.5	0.3	1.6	7.8	1.1	0.3	0.8	0.5	0.2	0.9	0.4	0.1	0.2	1.3	0.7	7	4.9	8	0.3	3.3	0.1	1.8	0.6	0.4	3	2	0.1	0.2	20.9	1.6	6	0.7	0.1	0.6	0.3	0.9	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.8	0	0.3	2	1.5	1	0.6	1.1	2.5	1.4	0	10.4	13.7	8.5	10	1.1	0	0.3	0	0	4.7	1.7	0.7	1.5	0	0.4	4.9	0	3.4	0	3.1	0	0.9	3.8	0	6.4	2.6	0.8	1.1	0	0.4	60.2	3.2	6.5	1	2.2	5.5	0.1	3.9	2.1	0.2	1.4	Proximal tubular cells
OR2T10		ENSG00000184022	Olfactory receptor family 2 subfamily T member 10	Q8NGZ9	1	248590487-248597700	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	8	kidney: 11.2	Cell type enriched	Detected in single	59	Proximal tubular cells: 5.9	Cancer enhanced	Detected in single		renal cancer: 0.7					Cell type enhanced	Detected in single		naive B-cell: 1.4	Lineage enriched	Detected in single	15	B-cells: 1.4	Group enriched	Detected in some	7	BJ hTERT+: 3.1;Karpas-707: 2.4									HPA052019	Uncertain											HPA052019: AB_2681696													unprognostic (8.58e-2)					0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0.1	0	0	0	0	11.2	0	0	0	0		0	0.3	0	0	0		0.4	0		0.1	0	0	0.2	0	0	0	0.1	0	0.1			0		0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	1.4	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SLC36A2	PAT2, TRAMD1, tramdorin	ENSG00000186335	Solute carrier family 36 member 2	Q495M3	5	151314978-151347590	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Amino-acid transport, Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1	Cell type enriched	Detected in some	9	Proximal tubular cells: 44.0	Cancer enriched	Detected in single	9	renal cancer: 0.5	Region enhanced	Detected in single		midbrain: 1.2	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HL-60: 1.9;NB-4: 2.0	Low region specificity	Detected in some			Low region specificity	Detected in single			HPA044002, HPA062229	Enhanced											HPA044002: AB_10964214, HPA062229: AB_2684717	unprognostic (3.47e-1)	unprognostic (3.40e-1)		unprognostic (2.26e-2)	unprognostic (6.23e-2)	unprognostic (8.38e-3)	unprognostic (4.66e-3)	unprognostic (3.03e-1)	unprognostic (7.73e-2)	unprognostic (1.92e-2)	unprognostic (2.11e-1)	unprognostic (1.92e-1)	unprognostic (1.20e-3)	unprognostic (1.43e-1)	unprognostic (1.05e-1)	unprognostic (2.18e-1)	unprognostic (3.89e-2)	0.6	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	2.6	0.5	0.1	0	0.2	0.1	0.1	60.3	0.1	0.1	0	1.2	0	0.1	0.1	0	0.1	0	0.4	0.1	0	1.1	2	0	36.8	0.1	0.1	0	0.2	0.1	0.1	0.7	0	0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1	0.4	0	0.1	0	0.6	0.3	0.8	0.3	0.2	0.3	0.4	0	0.7	0	1.5	1.5	0.3	0.8	0.3	0	1.9	0.5	0.1	0.1	0	0	0	0.5	0.5	0.1	1.4	0.2	0.3	0.4	2	1.2	0	0.2	0.5	0.4	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0	0.2	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0	0.4	0	0	0	0	0	0	0	0.6	0	0	0	1.8	0	0	5	0	4.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	44	0	0	0.3	0	0	0	0	0	0	0	Proximal tubular cells
OR2T2	OR2T2P	ENSG00000196240	Olfactory receptor family 2 subfamily T member 2	Q6IF00	1	248445512-248455725	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	7	kidney: 14.1	Cell type enriched	Detected in single	14	Proximal tubular cells: 1.4	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.9	Lineage enriched	Detected in single	20	B-cells: 1.9	Cell line enriched	Detected in single	22	Karpas-707: 3.2																																							0	0	0	0.2	0	0	0	0	0.1	0.3	0.1	0	0	0	0	2	0	0	0	0	0	0	14.1	0	0	1.5	0	0	0.2	0.1	0	0	0.2	0	0.4	0	0	0.1	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0.3	0	0.4	0.2	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SLC22A24	MGC34821, NET46	ENSG00000197658	Solute carrier family 22 member 24	Q8N4F4	11	63079940-63144221	Predicted membrane proteins, Transporters	Ion transport, Lipid metabolism, Steroid metabolism, Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	kidney: 10.5	Cell type enriched	Detected in single	30	Proximal tubular cells: 8.4	Cancer enriched	Detected in single	11	renal cancer: 0.5					Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA045015	Uncertain											HPA045015: AB_2679183							unprognostic (5.72e-3)						unprognostic (1.80e-7)					0	0	0	0	0.2	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	10.5	2.1	0	0	0		0	0.1	0	0	0		0	0		0	0	0	0	0	0	0	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SLC22A12	OAT4L, RST, URAT1	ENSG00000197891	Solute carrier family 22 member 12	Q96S37	11	64590641-64602353	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport		Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	349	kidney: 70.1	Cell type enriched	Detected in some	18	Proximal tubular cells: 149.1	Group enriched	Detected in some	207	liver cancer: 4.0;renal cancer: 16.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in single			Not detected	Not detected			HPA024575	Enhanced											HPA024575: AB_1858650					unprognostic (5.88e-2)		unprognostic (2.33e-1)						prognostic favorable (2.63e-4)	unprognostic (6.19e-2)	unprognostic (3.91e-2)			0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	70.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	1.8	0	0	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	149.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SLC22A6	OAT1, PAHT, ROAT1	ENSG00000197901	Solute carrier family 22 member 6	Q4U2R8	11	62936385-62984983	FDA approved drug targets, Predicted membrane proteins, Transporters			FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	kidney: 94.2	Cell type enriched	Detected in some	14	Proximal tubular cells: 213.4	Cancer enriched	Detected in single	102	renal cancer: 18.8	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA074559, CAB075704	Enhanced											CAB075704: , HPA074559: AB_2732260					unprognostic (2.42e-2)								unprognostic (2.25e-3)	unprognostic (4.43e-1)				0.2	0.2	0.8	0.2	1.3	0.2	0.2	0.4	1.4	0.2	0.2	0.7	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	1.8	94.2	0.2	0.2	0.2	2.4	0.6	0.2	0.2	0.2	0.1	0.2	4.1	0.2	0.2	9.4	0.2	0.2	0.2	0.2	0.2	0.2	2.4	0.2	0.2	0.2	0.5	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	1.3	0.4	1.4	0.8	1.8	2.4	0.6	4.1	0.5	0	0	0	0	0	0.4	0	0	0	0	7	0	0	14.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	213.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
MT1F	MT1	ENSG00000198417	Metallothionein 1F	P04733	16	56657694-56660698	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		kidney: 84.1;liver: 98.0;thyroid gland: 152.5	Cell type enriched	Detected in many	4	Proximal tubular cells: 4487.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	5	basophil: 14.7;classical monocyte: 10.2;gdT-cell: 14.0;MAIT T-cell: 12.7;memory B-cell: 7.4;memory CD4 T-cell: 15.3;memory CD8 T-cell: 23.9;naive CD4 T-cell: 15.2;naive CD8 T-cell: 25.4;T-reg: 23.9	Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HDLM-2: 18.4;NB-4: 29.8;NTERA-2: 19.1;RPTEC TERT1: 82.7;THP-1: 17.9;U-937: 16.0																						unprognostic (4.15e-2)	unprognostic (3.60e-2)	unprognostic (6.78e-2)	unprognostic (2.78e-2)	unprognostic (1.95e-3)	unprognostic (1.88e-3)	unprognostic (2.70e-1)	unprognostic (4.08e-2)	unprognostic (3.67e-1)	unprognostic (1.15e-1)	unprognostic (1.14e-1)	unprognostic (3.53e-1)	prognostic unfavorable (2.02e-7)	unprognostic (2.78e-1)	unprognostic (3.50e-2)	unprognostic (2.65e-2)	unprognostic (2.85e-1)	6.4	12.1	14.8	5.8	22.9	2.4	3.1	5.9	18.6	2.2	24.6	9.7	4.9	15.9	2.3	13.5	2.2	3.7	10.6	1.9	16	13.7	84.1	98	2.5	6.5	27.5	15.7	1.3	55.7	1.4	4.5	1.5	37	11.6	17.6	8.3	3.9	4.3	1.1	2	37.9	3.3	23.8	3.9	15.1	1.6	9.2	0	152.5	0	2.8	3.3	1.1	7.4	2.5	14.7	10.2	2.3	25.4	14.4	1.3	0.8	0	0	0	0	1.6	0.9	1.9	0.6	1.1	0.3	5	0	3.2	0.1	1.3	4.6	5.8	0.9	0.7	18.4	0.8	1.3	0.2	0.6	0.4	0	15.3	0.1	0.2	0.7	0.2	0.4	0	0.4	0	0	0	2.5	0	29.8	19.1	0.3	1.8	0	0	0.7	82.7	0.8	9.6	1.2	1.2	0.4	0.5	2.8	0.6	17.9	0	0	0.2	0.1	0	0	0	0	13.9	16	0.1	14.7	10.2	2.8	14	0.9	12.7	7.4	15.3	23.9	2.5	3	15.2	25.4	1.5	2.3	0.4	0.8	23.9	14.4	14.8	22.9	5.9	18.6	16	13.7	27.5	15.7	37	9.2	0	9.4	25.5	29.5	7.6	0	6.1	137.6	38.8	21.6	310.6	0	3.4	948.3	194.8	0.4	5.4	802.3	23.3	105.7	281.1	9.2	83.9	11.5	847	26.2	0	164.4	28.3	35.5	0	29.1	28.8	87.7	79.4	549.3	0	152.7	997.7	4.9	4487.9	0	6.5	36.6	0.2	1.7	6.9	16.2	34.8	560.8	18.8	Proximal tubular cells
SLC34A3	FLJ38680, NPTIIc	ENSG00000198569	Solute carrier family 34 member 3	Q8N130	9	137230757-137236554	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 10.4;kidney: 14.8	Cell type enriched	Detected in some	12	Proximal tubular cells: 20.3	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7	Low region specificity	Detected in single			Low region specificity	Detected in some			HPA023776	Enhanced											HPA023776: AB_1857102	unprognostic (2.69e-1)	unprognostic (4.16e-1)	unprognostic (9.08e-3)	unprognostic (1.83e-2)	unprognostic (2.41e-1)	unprognostic (1.29e-3)	unprognostic (4.02e-3)	unprognostic (1.75e-2)	unprognostic (1.05e-2)	unprognostic (9.84e-3)	unprognostic (2.05e-2)	unprognostic (2.20e-2)	unprognostic (5.94e-2)	unprognostic (1.94e-2)	unprognostic (9.12e-2)	unprognostic (5.80e-2)	unprognostic (2.20e-1)	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0	1.6	0.2	0.2	0.2	0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0	0	0	0	0	0	0	0.8	1.7	0.7	2	0	0	0.5	0.1	0	0	0	0.5	6	0.4	0.2	0	0.1	3	0	0	0	3.7	0.2	0	4	2.6	0	0	0.5	0	0	0	0	0.4	0	0.3	0.4	0.7	0	9.7	0.1	0.1	0.6	1.1	1.2	1.3	0.5	0	0	0.5	0	1.5	0.6	1.4	0.3	0.7	3.4	0.1	0.4	0.5	0.4	1.9	0.1	1.1	0.5	0.4	0.8	0.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0.3	0	0	0	0	0	0	1.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	20.3	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
ERICH4	C19orf69, LOC100170765	ENSG00000204978	Glutamate rich 4	A6NGS2	19	41443158-41444765	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	intestine: 78.1	Cell type enriched	Detected in some	6	Proximal tubular cells: 73.4	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	12	CACO-2: 4.8;Hep G2: 11.1;THP-1: 3.1	Not detected	Not detected			Low region specificity	Detected in many			HPA042632, HPA048484	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA042632: AB_2678090, HPA048484: AB_2680415	unprognostic (1.41e-1)	unprognostic (3.05e-1)	unprognostic (9.52e-2)	unprognostic (1.24e-1)	unprognostic (2.76e-1)		unprognostic (4.03e-5)	unprognostic (8.53e-2)		unprognostic (7.54e-2)	unprognostic (1.97e-1)	unprognostic (3.09e-2)	unprognostic (1.04e-1)	unprognostic (2.79e-1)	unprognostic (2.35e-1)	unprognostic (1.16e-1)		0.6	0	0.2	0.2	0.3	0	0.6	0.2	0.3	0.4	21	0.2	0.2	27.1	0.4	0.4	0.2	0.4	0.5	1.3	0.2	0	10	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.9	0	78.1	0.2	0.3	0.2	0.1	0.8	0.2	0.2	0.3	0.2	0.2	0.3	0.4	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	4.8	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0.1	11.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0.2	0.1	0	0	0	0	0	0	3.1	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0.3	0.2	0.3	0.2	0	0.3	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	1.8	0	0	11.6	0	3.1	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0.3	0	0.1	0	0	73.4	0	0	0	0.4	0.6	0	0	0	0	0	Proximal tubular cells
CTXN3		ENSG00000205279	Cortexin 3	Q4LDR2	5	127649044-127658630	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Group enriched	Detected in some	4	brain: 21.9;kidney: 58.1	Cell type enriched	Detected in some	6	Proximal tubular cells: 121.0	Cancer enriched	Detected in single	8	renal cancer: 1.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	AF22: 4.5;NTERA-2: 1.5	Low region specificity	Detected in many			Region enriched	Detected in many	4	olfactory region: 50.2																		unprognostic (7.32e-2)	unprognostic (9.88e-2)		unprognostic (1.19e-1)				unprognostic (1.29e-1)	unprognostic (6.20e-3)					0.6	0.6	2.2	0.5	9.4	0.5	0.6	0.2	19.1	0.6	0.6	0.7	0	0.5	0.6	0.5	0.6	0.6	0.6	0.6	7.9	4.8	58.1	0.6	0.6	0.6	12.6	4.6	0.5	0.5	0.5	5.9	0.5	21.9	0.9	0.6	0	0.7	0.6	9.1	0.5	0.5	0.5	0.5	0.5	0.6	0.6	1	0	0.5	0.3	0.5	0.6	0.1	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	9.4	0.2	19.1	7.9	4.8	12.6	4.6	21.9	1	0	0	0	0	0	0	0	0	0	0	3.5	0	0	19.9	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.6	0	0	0	0	0	0	0	0	121	0	0	0	0	0.1	0	0	0	0	0	Proximal tubular cells
DWORF		ENSG00000240045	DWARF open reading frame		3	155290229-155293775	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	7	skeletal muscle: 173.0	Cell type enriched	Detected in some	4	Proximal tubular cells: 7.9	Low cancer specificity	Detected in some							Cell type enhanced	Detected in single		basophil: 2.9	Lineage enriched	Detected in single	6	granulocytes: 2.9	Low cell line specificity	Detected in some			Region enriched	Detected in some	8	basal ganglia: 19.5																					unprognostic (6.77e-4)		unprognostic (1.60e-2)					unprognostic (6.62e-2)	unprognostic (1.58e-1)	unprognostic (7.82e-3)	unprognostic (1.33e-2)				0.4	0	0	0	1.4	0	0	0	0	0	0	0	0	0.7	0	5.2	2.9	0	0	0.6	0		0.7	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	1.6	0	173	0	0.3	0	0	0	0	0	1.6	0	0.7	23.7	0.9	0	0	0.5	0.4	2.9	0.2	0.4	0.2	0	0.2	0	0.6	0	0	2.3	0.7	0.3	0	0	0.6	0	1.3	0	0.4	0	0.4	0.5	0.3	0.5	0	0.3	0.6	0.4	0.5	0.5	0	1.8	0.4	2.1	0	0	0.5	0.4	0.8	0	0.6	1.3	1.2	0.4	0.2	1.7	1.2	0.7	0.6	0.3	0.2	0.3	0	0	1	0.9	0	0.7	0.1	1	0.9	1.1	1.9	1.8	1.3	0.8	0.2	0.2	0.3	0.8	0.8	0.3	0	2.9	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.5	0.2	0.2	0.8	0.4	0.1	0.4	0.1	0											0	0	0	0	0	0	0	0	0	0	1.8	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	7.9	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
C3orf85	FLJ22763	ENSG00000241224	Chromosome 3 open reading frame 85		3	109118252-109150514	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Tissue enriched	Detected in some	5	intestine: 50.1	Cell type enriched	Detected in some	7	Proximal tubular cells: 108.1	Cancer enhanced	Detected in some		colorectal cancer: 1.3					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.2;CACO-2: 5.0;RPMI-8226: 1.5;SH-SY5Y: 1.5	Not detected	Not detected			Not detected	Not detected																		unprognostic (9.10e-2)				unprognostic (9.48e-3)						unprognostic (3.80e-4)	unprognostic (1.15e-1)	unprognostic (6.70e-2)			0	0	0	2.5	0	0	0	0	0	0	14.6	0	0	36.2	0	0.6	0	0	0	0.4	0		6.8	9.8	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	50.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	5	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.4	0	0	0	1.5	0	0	0.2	1.5	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	5.2	0	0	14.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	108.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
AL845331.2		ENSG00000259916			2	94588522-94604573	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	13	adipose tissue: 12.1	Cell type enriched	Detected in single	10	Proximal tubular cells: 1.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	11	ASC diff: 6.8																						unprognostic (1.97e-1)				unprognostic (1.24e-1)		unprognostic (8.07e-3)	unprognostic (1.39e-1)		unprognostic (1.85e-1)	unprognostic (1.45e-1)	unprognostic (1.15e-1)	unprognostic (9.15e-3)	unprognostic (6.22e-2)		unprognostic (4.66e-2)		12.1	0.1		0		0	0.2		0	0	0			0	0	0	0	0	0	0.1			0.9	0.2	0	0			0	0	0		0		0	0		0.1	0	0	0	0	0		0	0	0			0		0	0		0	0	0	0	0	0	0	0	0	0	0.5	6.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
FIGNL2		ENSG00000261308	Fidgetin like 2	A6NMB9	12	51817840-51848766	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		kidney: 16.7	Cell type enriched	Detected in single	13	Proximal tubular cells: 7.6	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 16.7;BEWO: 10.8;NTERA-2: 6.6;SuSa: 12.9	Low region specificity	Detected in some			Low region specificity	Detected in many																unprognostic (1.83e-1)	unprognostic (3.77e-2)	unprognostic (2.26e-2)	unprognostic (7.36e-4)	unprognostic (1.99e-1)	unprognostic (2.45e-1)	unprognostic (1.57e-3)	unprognostic (2.71e-2)	unprognostic (4.75e-2)	unprognostic (6.40e-2)	unprognostic (9.78e-6)	unprognostic (7.95e-3)	unprognostic (9.65e-2)	unprognostic (1.15e-2)	unprognostic (1.31e-1)	unprognostic (1.01e-1)	unprognostic (1.48e-2)	1.1	0	0.6	0.6	0.7	0	1	0	2.2	1.4	0.1	0	0.4	0	2.6	0.9	0	0.2	0.3	1.5	0.1		16.7	1.4	2	0.7	0.2	1.7	0	0	4.3	0.1	1.9	1.3	0.9	0	1	1.8	0.5	2	0.2	0.4	0.2	0.2	1	0.9	1.3	0	0	0.2	0.5	0.3	0.2	0.8	0.4	0.8	0.2	0.2	0	0.5	0	0	0.1	16.7	0	0.2	0.1	10.8	0	0	0	0	3.3	0	0	1.6	0.1	0.1	0	0.6	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0.3	0	6.6	0	0.2	0	0	0	0.4	0	0.5	1.9	0	0	0	12.9	0	0	0	0.1	0.2	0	0	0	0	0	0	0.1	0	0.2	0.2	0	0.5	0	0.1	0	0.3	0.3	0.1	0.4	0.1	0.1	0	0	0.1	0.8	0	0											0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.6	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SMIM32		ENSG00000271824	Small integral membrane protein 32		5	136191468-136193134	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Group enriched	Detected in some	9	brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2	Cell type enriched	Detected in some	8	Proximal tubular cells: 233.2	Cancer enhanced	Detected in many		renal cancer: 12.4					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HaCaT: 2.3;SCLC-21H: 6.1	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (2.35e-5)	unprognostic (3.08e-1)	unprognostic (7.74e-2)	unprognostic (7.79e-2)	unprognostic (2.11e-2)	unprognostic (9.13e-2)	prognostic favorable (1.63e-4)	unprognostic (1.86e-2)		unprognostic (1.75e-2)	prognostic favorable (6.13e-4)	unprognostic (1.51e-1)	unprognostic (1.19e-2)	unprognostic (2.78e-1)	unprognostic (1.14e-1)	unprognostic (4.85e-3)	unprognostic (8.05e-2)	0	0	0	1.2	2.2	0	0	0	7.8	0	5.1	0	0	12.3	0	0	0	0	9.8	0	0.6		26.2	0	0	0	0	0.4	0	0	0	0	0	0.2	0.2	1.4	0.1	0	0	0.2	0	8.3	0	0	0	1.5	0	1.4	0	1.1	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0.2	0.1	0	0	0	0.4	0.1	0	0	0	0.2	0	0	0.3	0	0	2.3	0.2	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0.1	0.2	0	0.2	0	0	0.3	0	0	6.1	0.6	0	0	0	0.4	0	0.1	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	17.4	0	0	28.2	0	0	0	0	0	0.5	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	233.2	0	0	0	0	0	0	0.1	0	0	0	Proximal tubular cells
